| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1001 |
Improving the efficacy of inhaled drugs in cystic fibrosis: Challenges and emerging drug delivery strategies
|
d'Angelo, Ivana
|
|
2014
|
136-137 |
C |
p. 92-111
20 p.
|
artikel
|
| 1002 |
Improving vascularization of engineered bone through the generation of pro-angiogenic effects in co-culture systems
|
Unger, Ronald E.
|
|
2015
|
136-137 |
C |
p. 116-125
10 p.
|
artikel
|
| 1003 |
Influencing neuroplasticity in stroke treatment with advanced biomaterials-based approaches
|
Obermeyer, J.M.
|
|
|
136-137 |
C |
p. 204-218
|
artikel
|
| 1004 |
Ingestible devices for studying the gastrointestinal physiology and their application in oral biopharmaceutics
|
Weitschies, Werner
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1005 |
Ingestion-time differences in the pharmacodynamics of hypertension medications: Systematic review of human chronopharmacology trials
|
Hermida, Ramón C.
|
|
|
136-137 |
C |
p. 200-213
|
artikel
|
| 1006 |
Inhalation delivery technology for genome-editing of respiratory diseases
|
Chow, Michael Y.T.
|
|
|
136-137 |
C |
p. 217-228
|
artikel
|
| 1007 |
Inhalation of repurposed drugs to treat pulmonary hypertension
|
Gessler, Tobias
|
|
2018
|
136-137 |
C |
p. 34-44
|
artikel
|
| 1008 |
Inhaled anti-infective chemotherapy for respiratory tract infections: Successes, challenges and the road ahead
|
Velkov, Tony
|
|
2015
|
136-137 |
C |
p. 65-82
18 p.
|
artikel
|
| 1009 |
Inhaled antimicrobial chemotherapy for respiratory tract infections: successes, challenges and the road ahead
|
Chan, Hak-Kim
|
|
2015
|
136-137 |
C |
p. v-vii
nvt p.
|
artikel
|
| 1010 |
Inhaled antimicrobial therapy – Barriers to effective treatment
|
Weers, Jeffry
|
|
2015
|
136-137 |
C |
p. 24-43
20 p.
|
artikel
|
| 1011 |
Inhaled drug delivery for the targeted treatment of asthma
|
Boboltz, Allison
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1012 |
Inhaled formulations and pulmonary drug delivery systems for respiratory infections
|
Zhou, Qi (Tony)
|
|
2015
|
136-137 |
C |
p. 83-99
17 p.
|
artikel
|
| 1013 |
Inhaled RNA drugs to treat lung diseases: Disease-related cells and nano–bio interactions
|
Zhang, Mengjun
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1014 |
Injectable formulations of poly(lactic acid) and its copolymers in clinical use
|
Jain, Anjali
|
|
2016
|
136-137 |
C |
p. 213-227
|
artikel
|
| 1015 |
Injectable network biomaterials via molecular or colloidal self-assembly
|
Sahoo, Jugal Kishore
|
|
|
136-137 |
C |
p. 185-207
|
artikel
|
| 1016 |
Injectable systems for long-lasting insulin therapy
|
Niloy, Kumar Kulldeep
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1017 |
Innovative approaches to optimizing the delivery of vancomycin in individual patients
|
Pai, Manjunath P.
|
|
2014
|
136-137 |
C |
p. 50-57
8 p.
|
artikel
|
| 1018 |
Inorganic nanoparticles as scaffolds for bioorthogonal catalysts
|
Hirschbiegel, Cristina-Maria
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1019 |
IN.PACT™ Admiral™ drug-coated balloon: Durable, consistent and safe treatment for femoropopliteal peripheral artery disease
|
Peterson, Susan
|
|
2017
|
136-137 |
C |
p. 69-77
9 p.
|
artikel
|
| 1020 |
Insights into incretin-based therapies for treatment of diabetic dyslipidemia
|
Stemmer, Kerstin
|
|
|
136-137 |
C |
p. 34-53
|
artikel
|
| 1021 |
Insights into the key roles of epigenetics in matrix macromolecules-associated wound healing
|
Piperigkou, Zoi
|
|
|
136-137 |
C |
p. 16-36
|
artikel
|
| 1022 |
Insights into the use of genetically modified decellularized biomaterials for tissue engineering and regenerative medicine
|
Zhu, Danji
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1023 |
In silico methods for predicting drug–drug interactions with cytochrome P-450s, transporters and beyond
|
Ai, Ni
|
|
2015
|
136-137 |
C |
p. 46-60
15 p.
|
artikel
|
| 1024 |
In silico T cell epitope identification for SARS-CoV-2: Progress and perspectives
|
Sohail, Muhammad Saqib
|
|
|
136-137 |
C |
p. 29-47
|
artikel
|
| 1025 |
In situ activation of therapeutics through bioorthogonal catalysis
|
Wang, Wenjie
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1026 |
In situ cellular hitchhiking of nanoparticles for drug delivery
|
Udofa, Edidiong
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1027 |
In situ forming injectable hydrogels for drug delivery and wound repair
|
Dimatteo, Robert
|
|
|
136-137 |
C |
p. 167-184
|
artikel
|
| 1028 |
Instructive microenvironments in skin wound healing: Biomaterials as signal releasing platforms
|
Castaño, Oscar
|
|
|
136-137 |
C |
p. 95-117
|
artikel
|
| 1029 |
Insulin delivery systems combined with microneedle technology
|
Jin, Xuan
|
|
|
136-137 |
C |
p. 119-137
|
artikel
|
| 1030 |
Integrated modeling of biomarkers, survival and safety in clinical oncology drug development
|
Liu, Han
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1031 |
Integrated pharmacokinetic-pharmacodynamic and agent-based modelling in drug development: Current status and future perspectives
|
Yates, James W.T.
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1032 |
Integrating chemoradiation and molecularly targeted therapy
|
Wahl, Daniel R.
|
|
2017
|
136-137 |
C |
p. 74-83
10 p.
|
artikel
|
| 1033 |
Integrating microneedles and sensing strategies for diagnostic and monitoring applications: The state of the art
|
Pei, Shihao
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1034 |
Integrating nanomedicine into clinical radiotherapy regimens
|
DuRoss, Allison N.
|
|
|
136-137 |
C |
p. 35-56
|
artikel
|
| 1035 |
Integration of biomimicry and nanotechnology for significantly improved detection of circulating tumor cells (CTCs)
|
Myung, Ja Hye
|
|
|
136-137 |
C |
p. 36-47
|
artikel
|
| 1036 |
Integration of mesenchymal stem cells with nanobiomaterials for the repair of myocardial infarction
|
Han, Jin
|
|
2015
|
136-137 |
C |
p. 15-28
14 p.
|
artikel
|
| 1037 |
Integration of personalized drug delivery systems into digital health
|
Raijada, Dhara
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1038 |
Integrins in wound healing, fibrosis and tumor stroma: High potential targets for therapeutics and drug delivery
|
Schnittert, Jonas
|
|
|
136-137 |
C |
p. 37-53
|
artikel
|
| 1039 |
Interaction between high-density lipoproteins and inflammation: Function matters more than concentration!
|
Nazir, Sumra
|
|
|
136-137 |
C |
p. 94-119
|
artikel
|
| 1040 |
Interaction of 2D nanomaterial with cellular barrier: Membrane attachment and intracellular trafficking
|
Miao, Li
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1041 |
Interactions between nanoparticles and lymphatic systems: Mechanisms and applications in drug delivery
|
Tang, Yisi
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1042 |
Interactions between nanoparticles and pathological changes of vascular in Alzheimer’s disease
|
Lei, Ting
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1043 |
Interest of extracellular vesicles in regards to lipid nanoparticle based systems for intracellular protein delivery
|
Le Saux, Sarah
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1044 |
Interference of layered double hydroxide nanoparticles with pathways for biomedical applications
|
Jing, Guoxin
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1045 |
Intervertebral disc regeneration: From cell therapy to the development of novel bioinspired endogenous repair strategies
|
Clouet, Johann
|
|
2019
|
136-137 |
C |
p. 306-324
|
artikel
|
| 1046 |
Intracellular delivery of colloids: Past and future contributions from microinjection
|
Tiefenboeck, Peter
|
|
2018
|
136-137 |
C |
p. 3-15
|
artikel
|
| 1047 |
Intracellular spatiotemporal metabolism in connection to target engagement
|
Zhang, Jingwei
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1048 |
Intradermal and transdermal drug delivery using microneedles – Fabrication, performance evaluation and application to lymphatic delivery
|
Sabri, Akmal H.
|
|
|
136-137 |
C |
p. 195-215
|
artikel
|
| 1049 |
Intranasal and inhaled delivery systems for targeting circadian dysfunction in neurodegenerative disorders, perspective and future outlook
|
Ryan, Rhearne
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1050 |
Intranasal drug delivery: The interaction between nanoparticles and the nose-to-brain pathway
|
Chen, Yaoxing
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1051 |
Intranasal NAP (Davunetide): Neuroprotection and circadian rhythmicity
|
Galushkin, Artur
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1052 |
Intraperitoneal aerosolized drug delivery: Technology, recent developments, and future outlook
|
Rahimi-Gorji, Mohammad
|
|
|
136-137 |
C |
p. 105-114
|
artikel
|
| 1053 |
Intrathecal delivery and its applications in leptomeningeal disease
|
Khang, Minsoo
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1054 |
Intrathecal delivery of Macromolecules: Clinical status and emerging technologies
|
Ajeeb, Rana
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1055 |
Intrathecal drug delivery in the era of nanomedicine
|
Fowler, M.J.
|
|
|
136-137 |
C |
p. 77-95
|
artikel
|
| 1056 |
Intra-tumoral bacteria in breast cancer and intervention strategies
|
Hou, Ting
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1057 |
Intratumoral fate of functional nanoparticles in response to microenvironment factor: Implications on cancer diagnosis and therapy
|
Peng, Jinrong
|
|
|
136-137 |
C |
p. 37-67
|
artikel
|
| 1058 |
Intravital microscopy for real-time monitoring of drug delivery and nanobiological processes
|
Momoh, Jeffrey
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1059 |
Intrinsic cancer vaccination
|
Yang, Yoosoo
|
|
|
136-137 |
C |
p. 2-22
|
artikel
|
| 1060 |
Introducing article-based publishing (ABP) and Virtual Special Issue (VSI)
|
|
|
|
136-137 |
C |
p. A1
|
artikel
|
| 1061 |
Investigation of endosome and lysosome biology by ultra pH-sensitive nanoprobes
|
Wang, Chensu
|
|
2017
|
136-137 |
C |
p. 87-96
10 p.
|
artikel
|
| 1062 |
In vitro and ex vivo models for evaluating vaginal drug delivery systems
|
Shapiro, Rachel L.
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1063 |
In vitro and ex vivo models in inhalation biopharmaceutical research — advances, challenges and future perspectives
|
Selo, Mohammed Ali
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1064 |
In vitro and ex vivo models to study drug delivery barriers in the posterior segment of the eye
|
Peynshaert, Karen
|
|
2018
|
136-137 |
C |
p. 44-57
|
artikel
|
| 1065 |
In vitro cancer cell–ECM interactions inform in vivo cancer treatment
|
Holle, Andrew W.
|
|
2016
|
136-137 |
C |
p. 270-279
10 p.
|
artikel
|
| 1066 |
In vitro cardiac tissue models: Current status and future prospects
|
Mathur, Anurag
|
|
2016
|
136-137 |
C |
p. 203-213
11 p.
|
artikel
|
| 1067 |
In vitro digestion models to evaluate lipid based drug delivery systems; present status and current trends
|
Berthelsen, Ragna
|
|
2019
|
136-137 |
C |
p. 35-49
|
artikel
|
| 1068 |
In-vitro 3D modelling for charged particle therapy – Uncertainties and opportunities
|
Thiagarajan, Anuradha
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1069 |
“In vitro” 3D models of tumor-immune system interaction
|
Hirt, Christian
|
|
2014
|
136-137 |
C |
p. 145-154
10 p.
|
artikel
|
| 1070 |
In vitro, ex vivo and in vivo methods of lung absorption for inhaled drugs
|
Sakagami, Masahiro
|
|
|
136-137 |
C |
p. 63-74
|
artikel
|
| 1071 |
In vitro, in silico and integrated strategies for the estimation of plasma protein binding. A review
|
Lambrinidis, George
|
|
2015
|
136-137 |
C |
p. 27-45
19 p.
|
artikel
|
| 1072 |
In vitro-in vivo correlation of cascade impactor data for orally inhaled pharmaceutical aerosols
|
Chow, Michael Yee Tak
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1073 |
In vitro – in vivo correlation of intranasal drug deposition
|
Le Guellec, S.
|
|
|
136-137 |
C |
p. 340-352
|
artikel
|
| 1074 |
In vitro-in vivo correlation of pharmaceutical aerosols
|
Hickey, Anthony J.
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1075 |
In vitro-in vivo correlations (IVIVCs) of deposition for drugs given by oral inhalation
|
Newman, Stephen P.
|
|
|
136-137 |
C |
p. 135-147
|
artikel
|
| 1076 |
In vitro microbial culture models and their application in drug development
|
Vyawahare, Saurabh
|
|
2014
|
136-137 |
C |
p. 217-224
8 p.
|
artikel
|
| 1077 |
In vitro microenvironments to study breast cancer bone colonisation
|
Taubenberger, Anna V.
|
|
2014
|
136-137 |
C |
p. 135-144
10 p.
|
artikel
|
| 1078 |
In vitro modeling of the prostate cancer microenvironment
|
Ellem, Stuart J.
|
|
2014
|
136-137 |
C |
p. 214-221
8 p.
|
artikel
|
| 1079 |
In vitro models of tumor vessels and matrix: Engineering approaches to investigate transport limitations and drug delivery in cancer
|
Seo, Bo Ri
|
|
2014
|
136-137 |
C |
p. 205-216
12 p.
|
artikel
|
| 1080 |
In vitro models to evaluate ingestible devices: Present status and current trends
|
O'Farrell, Connor
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1081 |
In vitro transcribed mRNA for expression of designer nucleases: Advantages as a novel therapeutic for the management of chronic HBV infection
|
Ely, Abdullah
|
|
|
136-137 |
C |
p. 134-146
|
artikel
|
| 1082 |
In vivo delivery of miRNAs for cancer therapy: Challenges and strategies
|
Chen, Yunching
|
|
2015
|
136-137 |
C |
p. 128-141
14 p.
|
artikel
|
| 1083 |
In vivo deposition of poorly soluble drugs
|
Lou, Zhaohuan
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1084 |
In vivo fate and intracellular trafficking of vaccine delivery systems
|
Lee, Jaiwoo
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1085 |
In vivo models of mucin biosynthesis and function
|
Syed, Zulfeqhar A.
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1086 |
In vivo models to evaluate ingestible devices: Present status and current trends
|
Stamatopoulos, Konstantinos
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1087 |
In vivo reprogramming of immune cells: Technologies for induction of antigen-specific tolerance
|
Pearson, Ryan M.
|
|
2017
|
136-137 |
C |
p. 240-255
|
artikel
|
| 1088 |
Iron oxide nanoparticles: Diagnostic, therapeutic and theranostic applications
|
Dadfar, Seyed Mohammadali
|
|
2019
|
136-137 |
C |
p. 302-325
|
artikel
|
| 1089 |
Isolation and identification of bacteria by means of Raman spectroscopy
|
Pahlow, Susanne
|
|
2015
|
136-137 |
C |
p. 105-120
16 p.
|
artikel
|
| 1090 |
Jet injectors: Perspectives for small volume delivery with lasers
|
Schoppink, Jelle
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1091 |
Key players in the immune response to biomaterial scaffolds for regenerative medicine
|
Chung, Liam
|
|
2017
|
136-137 |
C |
p. 184-192
|
artikel
|
| 1092 |
Killing two birds or more with one stone
|
Heo, Chan Yeong
|
|
2016
|
136-137 |
C |
p. 1-2
2 p.
|
artikel
|
| 1093 |
Label-free cytokine micro- and nano-biosensing towards personalized medicine of systemic inflammatory disorders
|
Chen, Pengyu
|
|
2015
|
136-137 |
C |
p. 90-103
14 p.
|
artikel
|
| 1094 |
Lack of predictive tools for conventional and targeted cancer therapy: Barriers to biomarker development and clinical translation
|
Batis, Nikolaos
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1095 |
Large-scale production of human pluripotent stem cell derived cardiomyocytes
|
Kempf, Henning
|
|
2016
|
136-137 |
C |
p. 18-30
13 p.
|
artikel
|
| 1096 |
Laser ablation: Heating up the anti-tumor response in the intracranial compartment
|
Lerner, Emily C.
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1097 |
Lessons from patient-derived xenografts for better in vitro modeling of human cancer
|
Choi, Stephen Yiu Chuen
|
|
2014
|
136-137 |
C |
p. 222-237
16 p.
|
artikel
|
| 1098 |
Lessons learned from intervertebral disc pathophysiology to guide rational design of sequential delivery systems for therapeutic biological factors
|
Frapin, Leslie
|
|
|
136-137 |
C |
p. 49-71
|
artikel
|
| 1099 |
Let's get small (and smaller): Combining zebrafish and nanomedicine to advance neuroregenerative therapeutics
|
White, David T.
|
|
|
136-137 |
C |
p. 344-359
|
artikel
|
| 1100 |
Let’s talk about sex: Differences in drug therapy in males and females
|
Madla, Christine M.
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1101 |
Letter to the editor
|
Furka, Árpád
|
|
|
136-137 |
C |
p. 151
|
artikel
|
| 1102 |
Leveraging advances in immunopathology and artificial intelligence to analyze in vitro tumor models in composition and space
|
Leong, Tze Ker Matthew
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1103 |
Leveraging macrophages for cancer theranostics
|
Liu, Lu
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1104 |
Leveraging the interplay of nanotechnology and neuroscience: Designing new avenues for treating central nervous system disorders
|
Smith, Elizabeth S.
|
|
|
136-137 |
C |
p. 181-203
|
artikel
|
| 1105 |
Leveraging the neurosurgical operating room for therapeutic development in NeuroOncology
|
Lowe, Stephen R.
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1106 |
Ligand density on nanoparticles: A parameter with critical impact on nanomedicine
|
Alkilany, Alaaldin M.
|
|
|
136-137 |
C |
p. 22-36
|
artikel
|
| 1107 |
Light and drug delivery-based antimicrobial therapies in the fight against infectious diseases
|
Dai, Tianhong
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1108 |
Light in evaluation of molecular diffusion in tissues: Discrimination of pathologies
|
Oliveira, Luís R.
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1109 |
Light-responsive nanomedicine for biophotonic imaging and targeted therapy
|
Son, Jihwan
|
|
2019
|
136-137 |
C |
p. 133-147
|
artikel
|
| 1110 |
Lights out for Superbugs: Is antimicrobial blue light a potential approach for future infection Control?
|
Ozdemir, Gizem D.
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1111 |
Light-triggered photodynamic nanomedicines for overcoming localized therapeutic efficacy in cancer treatment
|
Choi, Jiwoong
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1112 |
Limiting angiogenesis to modulate scar formation
|
Korntner, Stefanie
|
|
2019
|
136-137 |
C |
p. 170-189
|
artikel
|
| 1113 |
Linking autoantigen properties to mechanisms of immunity
|
Griffin, J. Daniel
|
|
|
136-137 |
C |
p. 105-116
|
artikel
|
| 1114 |
Lipid-based carriers for pulmonary products: Preclinical development and case studies in humans
|
Cipolla, David
|
|
2014
|
136-137 |
C |
p. 53-80
28 p.
|
artikel
|
| 1115 |
Lipid-based microbubbles and ultrasound for therapeutic application
|
Omata, Daiki
|
|
|
136-137 |
C |
p. 236-244
|
artikel
|
| 1116 |
Lipid based nanocarriers for effective drug delivery and treatment of diabetes associated liver fibrosis
|
Salunkhe, Shubham A.
|
|
|
136-137 |
C |
p. 394-415
|
artikel
|
| 1117 |
Lipid-based nanoparticle technologies for liver targeting
|
Böttger, Roland
|
|
|
136-137 |
C |
p. 79-101
|
artikel
|
| 1118 |
Lipid efflux mechanisms, relation to disease and potential therapeutic aspects
|
Castaño, David
|
|
|
136-137 |
C |
p. 54-93
|
artikel
|
| 1119 |
Lipid in the midst of metabolic remodeling – Therapeutic implications for the failing heart
|
Nguyen, T. Dung
|
|
|
136-137 |
C |
p. 120-132
|
artikel
|
| 1120 |
Lipid nanoparticle formulations for targeting leukocytes with therapeutic RNA in liver fibrosis
|
Bartneck, Matthias
|
|
|
136-137 |
C |
p. 70-88
|
artikel
|
| 1121 |
Lipid nanoparticle-mediated drug delivery to the brain
|
Khare, Purva
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1122 |
Lipid nanoparticles for nucleic acid delivery: Current perspectives
|
Samaridou, Eleni
|
|
|
136-137 |
C |
p. 37-63
|
artikel
|
| 1123 |
Lipid nanoparticles for RNA delivery: Self-assembling vs driven-assembling strategies
|
Nele, Valeria
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1124 |
Lipid nanoparticles for targeted delivery of anticancer therapeutics: Recent advances in development of siRNA and lipoprotein-mimicking nanocarriers
|
Yaghmur, Anan
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1125 |
Lipid nanoparticles (LNPs) for in vivo RNA delivery and their breakthrough technology for future applications
|
Jeong, Michaela
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1126 |
Lipid nanoparticles strategies to modify pharmacokinetics of central nervous system targeting drugs: Crossing or circumventing the blood–brain barrier (BBB) to manage neurological disorders
|
Correia, A.C.
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1127 |
Lipid nanoparticle technology for therapeutic gene regulation in the liver
|
Witzigmann, Dominik
|
|
|
136-137 |
C |
p. 344-363
|
artikel
|
| 1128 |
“Lipidomics”: Mass spectrometric and chemometric analyses of lipids
|
Wu, Zhuojun
|
|
|
136-137 |
C |
p. 294-307
|
artikel
|
| 1129 |
Lipids and cancer: Emerging roles in pathogenesis, diagnosis and therapeutic intervention
|
Butler, Lisa M.
|
|
|
136-137 |
C |
p. 245-293
|
artikel
|
| 1130 |
Lipids in disease pathology, diagnosis & therapy
|
Lammers, Twan
|
|
|
136-137 |
C |
p. 1-3
|
artikel
|
| 1131 |
Lipoprotein-based drug delivery
|
Busatto, Sara
|
|
|
136-137 |
C |
p. 377-390
|
artikel
|
| 1132 |
Lipoproteins and lipids in cardiovascular disease: from mechanistic insights to therapeutic targeting
|
Soppert, Josefin
|
|
|
136-137 |
C |
p. 4-33
|
artikel
|
| 1133 |
Liposomal delivery systems and their applications against Staphylococcus aureus and Methicillin-resistant Staphylococcus aureus
|
Nwabuife, Joshua C.
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1134 |
Liposomal formulations for treating lysosomal storage disorders
|
Tomsen-Melero, Judit
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1135 |
Liposomal siRNA nanocarriers for cancer therapy
|
Ozpolat, Bulent
|
|
2014
|
136-137 |
C |
p. 110-116
7 p.
|
artikel
|
| 1136 |
Liposome composition in drug delivery design, synthesis, characterization, and clinical application
|
Large, Danielle E.
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1137 |
Liposomes: Advancements and innovation in the manufacturing process
|
Shah, Sanket
|
|
|
136-137 |
C |
p. 102-122
|
artikel
|
| 1138 |
Listening for the therapeutic window: Advances in drug delivery utilizing photoacoustic imaging
|
Moore, Colman
|
|
|
136-137 |
C |
p. 78-89
|
artikel
|
| 1139 |
Listening to drug delivery and responses via photoacoustic imaging
|
Park, Byullee
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1140 |
Live attenuated and inactivated viral vaccine formulation and nasal delivery: Potential and challenges
|
Tlaxca, José L.
|
|
2015
|
136-137 |
C |
p. 56-78
23 p.
|
artikel
|
| 1141 |
Live long and active: Polypeptide-mediated assembly of antibody variable fragments
|
Lee, Changrim
|
|
|
136-137 |
C |
p. 1-18
|
artikel
|
| 1142 |
Local delivery of adenosine receptor agonists to promote bone regeneration and defect healing
|
Lopez, Christopher D.
|
|
2019
|
136-137 |
C |
p. 240-247
|
artikel
|
| 1143 |
Local delivery of macromolecules to treat diseases associated with the colon
|
Bak, A.
|
|
2018
|
136-137 |
C |
p. 2-27
|
artikel
|
| 1144 |
Local delivery strategies to restore immune homeostasis in the context of inflammation
|
Bentley, Elizabeth R.
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1145 |
Local pharmacological induction of angiogenesis: Drugs for cells and cells as drugs
|
Gaspar, Diana
|
|
2019
|
136-137 |
C |
p. 126-154
|
artikel
|
| 1146 |
Local scaffold-assisted delivery of immunotherapeutic agents for improved cancer immunotherapy
|
Shang, Qi
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1147 |
Long-acting inhaled medicines: Present and future
|
Zhang, Chengqian
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1148 |
Long-acting intrauterine systems: Recent advances, current challenges, and future opportunities
|
Fanse, Suraj
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1149 |
Long-acting microneedle formulations
|
Vora, Lalitkumar K.
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1150 |
Long-acting parenteral drug delivery systems for the treatment of chronic diseases
|
Jindal, Anil B.
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1151 |
Long-acting PLGA microspheres: Advances in excipient and product analysis toward improved product understanding
|
Wan, Bo
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1152 |
Long-acting therapeutic delivery systems for the treatment of gliomas
|
Padmakumar, Smrithi
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1153 |
Long-acting therapeutics: Development strategies and clinical significance
|
Jain, Sanyog
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1154 |
Long-acting transdermal drug delivery formulations: Current developments and innovative pharmaceutical approaches
|
Karve, Tanvi
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1155 |
Long-acting vaccine delivery systems
|
Walvekar, Pavan
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1156 |
Loops and layers of post-translational modifications of drug transporters
|
Xu, Da
|
|
2017
|
136-137 |
C |
p. 37-44
8 p.
|
artikel
|
| 1157 |
Lumican as a multivalent effector in wound healing
|
Karamanou, Konstantina
|
|
|
136-137 |
C |
p. 344-351
|
artikel
|
| 1158 |
Luminescent quantum dots: Synthesis, optical properties, bioimaging and toxicity
|
Sobhanan, Jeladhara
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1159 |
Lymphatic changes in cancer and drug delivery to the lymphatics in solid tumors
|
Cote, Brianna
|
|
|
136-137 |
C |
p. 16-34
|
artikel
|
| 1160 |
Lymphatic immunomodulation using engineered drug delivery systems for cancer immunotherapy
|
Manspeaker, Margaret P.
|
|
|
136-137 |
C |
p. 19-35
|
artikel
|
| 1161 |
Lymphatics in nanophysiology
|
Hirakawa, Satoshi
|
|
2014
|
136-137 |
C |
p. 12-18
7 p.
|
artikel
|
| 1162 |
Lymph-directed immunotherapy – Harnessing endogenous lymphatic distribution pathways for enhanced therapeutic outcomes in cancer
|
Feeney, Orlagh M.
|
|
|
136-137 |
C |
p. 115-135
|
artikel
|
| 1163 |
Lyophilized liposome-based parenteral drug development: Reviewing complex product design strategies and current regulatory environments
|
Wang, Yuwei
|
|
|
136-137 |
C |
p. 56-71
|
artikel
|
| 1164 |
Lysosomal enzyme replacement therapies: Historical development, clinical outcomes, and future perspectives
|
Solomon, Melani
|
|
2017
|
136-137 |
C |
p. 109-134
|
artikel
|
| 1165 |
Lysosomal functions and dysfunctions: Molecular and cellular mechanisms underlying Gaucher disease and its association with Parkinson disease
|
Horowitz, Mia
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1166 |
Lysosomal-mediated drug release and activation for cancer therapy and immunotherapy
|
Sun, Yinping
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1167 |
Lysosomal nanotoxicity: Impact of nanomedicines on lysosomal function
|
Uzhytchak, Mariia
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1168 |
Machine learning directed drug formulation development
|
Bannigan, Pauric
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1169 |
(Macro)molecular self-assembly for hydrogel drug delivery
|
Webber, Matthew J.
|
|
|
136-137 |
C |
p. 275-295
|
artikel
|
| 1170 |
Macrophage-based therapeutic strategies in regenerative medicine
|
Spiller, Kara L.
|
|
2017
|
136-137 |
C |
p. 74-83
|
artikel
|
| 1171 |
Magnetic iron oxide nanoparticles for brain imaging and drug delivery
|
Qiao, Ruirui
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1172 |
Magnetic resonance guided high-intensity focused ultrasound for image-guided temperature-induced drug delivery
|
Hijnen, Nicole
|
|
2014
|
136-137 |
C |
p. 65-81
17 p.
|
artikel
|
| 1173 |
Mastering the Gram-negative bacterial barrier – Chemical approaches to increase bacterial bioavailability of antibiotics
|
Ropponen, Henni-Karoliina
|
|
|
136-137 |
C |
p. 339-360
|
artikel
|
| 1174 |
Materials and device design for advanced phototherapy systems
|
Seung Lee, Ju
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1175 |
Materials for restoring lost Activity: Old drugs for new bugs
|
Pajares-Chamorro, Natalia
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1176 |
Matricellular proteins in drug delivery: Therapeutic targets, active agents, and therapeutic localization
|
Sawyer, Andrew J.
|
|
2016
|
136-137 |
C |
p. 56-68
13 p.
|
artikel
|
| 1177 |
Matrices for combined delivery of proteins and synthetic molecules
|
Gilmore, Kelly A.
|
|
2016
|
136-137 |
C |
p. 77-85
9 p.
|
artikel
|
| 1178 |
Matrigel: From discovery and ECM mimicry to assays and models for cancer research
|
Benton, Gabriel
|
|
2014
|
136-137 |
C |
p. 3-18
16 p.
|
artikel
|
| 1179 |
Matrikines as mediators of tissue remodelling
|
Jariwala, Nathan
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1180 |
Matrix-assisted cell transplantation for tissue vascularization
|
Browne, Shane
|
|
2019
|
136-137 |
C |
p. 155-169
|
artikel
|
| 1181 |
Maturing human pluripotent stem cell-derived cardiomyocytes in human engineered cardiac tissues
|
Feric, Nicole T.
|
|
2016
|
136-137 |
C |
p. 110-134
25 p.
|
artikel
|
| 1182 |
Maximizing therapeutic potential and safety: Exploring multi/dual-payload antibody conjugates as cancer theranostics
|
Khosravifarsani, Meysam
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1183 |
May carriers at nanoscale improve the Endodontic’s future?
|
Diogo, Patrícia
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1184 |
Measuring drug distribution in the critically ill patient
|
Deitchman, Amelia N.
|
|
2014
|
136-137 |
C |
p. 22-26
5 p.
|
artikel
|
| 1185 |
Mechanical regulation of vascular network formation in engineered matrices
|
Lesman, Ayelet
|
|
2016
|
136-137 |
C |
p. 176-182
7 p.
|
artikel
|
| 1186 |
Mechanical stimulation in the engineering of heart muscle
|
Liaw, Norman Yu
|
|
2016
|
136-137 |
C |
p. 156-160
5 p.
|
artikel
|
| 1187 |
Mechanisms of immune response to inorganic nanoparticles and their degradation products
|
Mohammapdour, Raziye
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1188 |
Mechanisms of β-lactam antimicrobial resistance and epidemiology of major community- and healthcare-associated multidrug-resistant bacteria
|
Tang, Sarah S.
|
|
2014
|
136-137 |
C |
p. 3-13
11 p.
|
artikel
|
| 1189 |
Mechanistical retinal drug targets and challenges
|
Kaarniranta, Kai
|
|
2018
|
136-137 |
C |
p. 177-184
|
artikel
|
| 1190 |
Mechanobiology of cancer cell responsiveness to chemotherapy and immunotherapy: Mechanistic insights and biomaterial platforms
|
Shakiba, Delaram
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1191 |
Mechanoresponsive materials for drug delivery: Harnessing forces for controlled release
|
Wang, Julia
|
|
2017
|
136-137 |
C |
p. 68-82
15 p.
|
artikel
|
| 1192 |
Mechanotherapy in oncology: Targeting nuclear mechanics and mechanotransduction
|
Liu, Shaobao
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1193 |
Medical devices, smart drug delivery, wearables and technology for the treatment of Diabetes Mellitus
|
Domingo-Lopez, Daniel A.
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1194 |
Meeting the challenges of advanced drug delivery in critical illness
|
Roberts, Jason A.
|
|
2014
|
136-137 |
C |
p. 1-2
2 p.
|
artikel
|
| 1195 |
Meet me halfway: Are in vitro 3D cancer models on the way to replace in vivo models for nanomedicine development?
|
Pozzi, Sabina
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1196 |
Membrane-core nanoparticles for cancer nanomedicine
|
Guo, Jianfeng
|
|
|
136-137 |
C |
p. 23-39
|
artikel
|
| 1197 |
MEMS devices for drug delivery
|
Lee, Hyunjoo J.
|
|
2018
|
136-137 |
C |
p. 132-147
|
artikel
|
| 1198 |
Merging data curation and machine learning to improve nanomedicines
|
Chen, Chen
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1199 |
Mesenchymal stem cells: A living carrier for active tumor-targeted delivery
|
Zhang, Tianyuan
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1200 |
Mesenchymal stromal cells for sphincter regeneration
|
Klein, Gerd
|
|
2015
|
136-137 |
C |
p. 123-136
14 p.
|
artikel
|
| 1201 |
Mesoporous silica nanoparticles for pulmonary drug delivery
|
García-Fernández, Alba
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1202 |
Messenger RNA-based vaccines: Past, present, and future directions in the context of the COVID-19 pandemic
|
Jain, Samagra
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1203 |
Metal nanobullets for multidrug resistant bacteria and biofilms
|
Chen, Ching-Wen
|
|
2014
|
136-137 |
C |
p. 88-104
17 p.
|
artikel
|
| 1204 |
Metal-organic frameworks for therapeutic gas delivery
|
Zhou, Yingzhu
|
|
|
136-137 |
C |
p. 199-214
|
artikel
|
| 1205 |
Micro- and nanocarriers for pain alleviation
|
da Silva, Alexandre
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1206 |
Micro and nanomotors in diagnostics
|
Chałupniak, Andrzej
|
|
2015
|
136-137 |
C |
p. 104-116
13 p.
|
artikel
|
| 1207 |
Micro and nanoscale technologies in oral drug delivery
|
Ahadian, Samad
|
|
|
136-137 |
C |
p. 37-62
|
artikel
|
| 1208 |
Microarray patches: Breaking down the barriers to contraceptive care and HIV prevention for women across the globe
|
Paredes, Alejandro J.
|
|
|
136-137 |
C |
p. 331-348
|
artikel
|
| 1209 |
Microarray patches enable the development of skin-targeted vaccines against COVID-19
|
Korkmaz, Emrullah
|
|
|
136-137 |
C |
p. 164-186
|
artikel
|
| 1210 |
Microbicide vaginal rings: Technological challenges and clinical development
|
Malcolm, R. Karl
|
|
|
136-137 |
C |
p. 33-56
|
artikel
|
| 1211 |
Microbiome as an immune regulator in health, disease, and therapeutics
|
Juarez, Valeria M.
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1212 |
Microbiota and cancer: In vitro and in vivo models to evaluate nanomedicines
|
Ladaycia, Abdallah
|
|
|
136-137 |
C |
p. 44-70
|
artikel
|
| 1213 |
Microbiota and plant-derived vesicles that serve as therapeutic agents and delivery carriers to regulate metabolic syndrome
|
Niu, Guanting
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1214 |
Microbubble-assisted ultrasound for inner ear drug delivery
|
Micaletti, Fabrice
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1215 |
Microchip-based detection of magnetically labeled cancer biomarkers
|
Muluneh, Melaku
|
|
2014
|
136-137 |
C |
p. 101-109
9 p.
|
artikel
|
| 1216 |
Microfluidic Devices for Drug Delivery Systems
|
Tokeshi, Manabu
|
|
2018
|
136-137 |
C |
p. 1-2
|
artikel
|
| 1217 |
Microfluidic 3D models of cancer
|
Sung, Kyung Eun
|
|
2014
|
136-137 |
C |
p. 68-78
11 p.
|
artikel
|
| 1218 |
Microfluidic fabrication of lipid nanoparticles for the delivery of nucleic acids
|
Prakash, Gyan
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1219 |
Microfluidics for nano-pathophysiology
|
Sato, Kae
|
|
2014
|
136-137 |
C |
p. 115-121
7 p.
|
artikel
|
| 1220 |
Microfluidics for producing poly (lactic-co-glycolic acid)-based pharmaceutical nanoparticles
|
Li, Xuanyu
|
|
2018
|
136-137 |
C |
p. 101-114
|
artikel
|
| 1221 |
Microfluidics in nanoparticle drug delivery; From synthesis to pre-clinical screening
|
Ahn, Jungho
|
|
2018
|
136-137 |
C |
p. 29-53
|
artikel
|
| 1222 |
Micromotors for drug delivery in vivo: The road ahead
|
Srivastava, Sarvesh Kumar
|
|
2019
|
136-137 |
C |
p. 41-55
|
artikel
|
| 1223 |
Microneedle-Mediated Vaccination: Innovation and Translation
|
Sheng, Tao
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1224 |
Microneedles for advanced ocular drug delivery
|
Glover, Katie
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1225 |
Micro-patterned cell populations as advanced pharmaceutical drugs with precise functional control
|
Che, Hui
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1226 |
Microphysiological systems meet hiPSC technology – New tools for disease modeling of liver infections in basic research and drug development
|
Raasch, Martin
|
|
2019
|
136-137 |
C |
p. 51-67
|
artikel
|
| 1227 |
Microphysiological systems of the placental barrier
|
Arumugasaamy, Navein
|
|
|
136-137 |
C |
p. 161-175
|
artikel
|
| 1228 |
MicroRNA delivery for regenerative medicine
|
Peng, Bo
|
|
2015
|
136-137 |
C |
p. 108-122
15 p.
|
artikel
|
| 1229 |
MicroRNA-mediated immune modulation as a therapeutic strategy in host-implant integration
|
Ong, Siew-Min
|
|
2015
|
136-137 |
C |
p. 92-107
16 p.
|
artikel
|
| 1230 |
MicroRNA-mediated regulation of differentiation and trans-differentiation in stem cells
|
Ong, Sang-Ging
|
|
2015
|
136-137 |
C |
p. 3-15
13 p.
|
artikel
|
| 1231 |
MicroRNAs and their delivery in diabetic fibrosis
|
Wonnacott, Alexa
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1232 |
MicroRNAs and their potential therapeutic applications in neural tissue engineering
|
Nguyen, Lan Huong
|
|
2015
|
136-137 |
C |
p. 53-66
14 p.
|
artikel
|
| 1233 |
MicroRNAs in liver tissue engineering — New promises for failing organs
|
Raschzok, Nathanael
|
|
2015
|
136-137 |
C |
p. 67-77
11 p.
|
artikel
|
| 1234 |
MicroRNAs in skin tissue engineering
|
Miller, Kyle J.
|
|
2015
|
136-137 |
C |
p. 16-36
21 p.
|
artikel
|
| 1235 |
MicroRNAs in the pathogenesis and treatment of progressive liver injury in NAFLD and liver fibrosis
|
Su, Qiaozhu
|
|
|
136-137 |
C |
p. 54-63
|
artikel
|
| 1236 |
MicroRNAs in tissue engineering & regenerative medicine
|
Chew, Sing Yian
|
|
2015
|
136-137 |
C |
p. 1-2
2 p.
|
artikel
|
| 1237 |
MicroRNAs in vascular tissue engineering and post-ischemic neovascularization
|
Caputo, Massimo
|
|
2015
|
136-137 |
C |
p. 78-91
14 p.
|
artikel
|
| 1238 |
MicroRNA-targeting nanomedicines for the treatment of intervertebral disc degeneration
|
Genedy, Hussein H.
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1239 |
Microspheres as intraocular therapeutic tools in chronic diseases of the optic nerve and retina
|
Bravo-Osuna, Irene
|
|
2018
|
136-137 |
C |
p. 127-144
|
artikel
|
| 1240 |
MIDD in Japan– Implementations, challenges and opportunities
|
Hasegawa, Mayumi
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1241 |
Mimicking oxygen delivery and waste removal functions of blood
|
Zhang, Huaifa
|
|
2017
|
136-137 |
C |
p. 84-104
|
artikel
|
| 1242 |
Miniaturized pre-clinical cancer models as research and diagnostic tools
|
Håkanson, Maria
|
|
2014
|
136-137 |
C |
p. 52-66
15 p.
|
artikel
|
| 1243 |
Miniaturized therapeutic systems for ultrasound-modulated drug delivery to the central and peripheral nervous system
|
Zhu, Pancheng
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1244 |
miRNA delivery for skin wound healing
|
Meng, Zhao
|
|
|
136-137 |
C |
p. 308-318
|
artikel
|
| 1245 |
MiRNA inhibition in tissue engineering and regenerative medicine
|
Beavers, Kelsey R.
|
|
2015
|
136-137 |
C |
p. 123-137
15 p.
|
artikel
|
| 1246 |
miRNAs as targets for cancer treatment: Therapeutics design and delivery
|
Li, Feng
|
|
2015
|
136-137 |
C |
p. v-vi
nvt p.
|
artikel
|
| 1247 |
miRNAs in pancreatic cancer: Therapeutic potential, delivery challenges and strategies
|
Chitkara, Deepak
|
|
2015
|
136-137 |
C |
p. 34-52
19 p.
|
artikel
|
| 1248 |
Mitochondrial endogenous substance transport-inspired nanomaterials for mitochondria-targeted gene delivery
|
Wang, Yi
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1249 |
Model-informed drug development in pediatric, pregnancy and geriatric drug development: States of the art and future
|
Wu, Yue-E
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1250 |
Model-informed precision dosing: State of the art and future perspectives
|
Minichmayr, I.K.
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1251 |
Modeling human carcinomas: Physiologically relevant 3D models to improve anti-cancer drug development
|
Unger, Christine
|
|
2014
|
136-137 |
C |
p. 50-67
18 p.
|
artikel
|
| 1252 |
Modeling mucus physiology and pathophysiology in human organs-on-chips
|
Izadifar, Zohreh
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1253 |
Models to study basic and applied aspects of lysosomal storage disorders
|
Gaudioso, Ángel
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1254 |
Models using native tracheobronchial mucus in the context of pulmonary drug delivery research: Composition, structure and barrier properties
|
Huck, Benedikt C.
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1255 |
Modified nucleobase-specific gene regulation using engineered transcription activator-like effectors
|
Tsuji, Shogo
|
|
|
136-137 |
C |
p. 59-65
|
artikel
|
| 1256 |
Modular design principle based on compartmental drug delivery systems
|
Eleftheriadis, Georgios K.
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1257 |
Modulating angiogenesis with integrin-targeted nanomedicines
|
Duro-Castano, Aroa
|
|
2017
|
136-137 |
C |
p. 101-119
|
artikel
|
| 1258 |
Modulating intracellular pathways to improve non-viral delivery of RNA therapeutics
|
Van de Vyver, Thijs
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1259 |
Modulating the electronic structure of graphdiyne-based nanomaterials for engineering nano-bio interfaces in biomedical applications
|
Wang, Hui
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1260 |
Modulating the foreign body response of implants for diabetes treatment
|
Kharbikar, Bhushan N.
|
|
|
136-137 |
C |
p. 87-113
|
artikel
|
| 1261 |
Modulating the immune system towards a functional chronic wound healing: A biomaterials and Nanomedicine perspective
|
Las Heras, Kevin
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1262 |
Modulating tumor physical microenvironment for fueling CAR-T cell therapy
|
Luo, Zhong
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1263 |
Molecular analysis of circulating tumors cells: Biomarkers beyond enumeration
|
Hwang, William L.
|
|
|
136-137 |
C |
p. 122-131
|
artikel
|
| 1264 |
Molecular and biological rationale of hyperthermia as radio- and chemosensitizer
|
Oei, A.L.
|
|
|
136-137 |
C |
p. 84-97
|
artikel
|
| 1265 |
Molecular deconstruction, detection, and computational prediction of microenvironment-modulated cellular responses to cancer therapeutics
|
LaBarge, Mark A.
|
|
2014
|
136-137 |
C |
p. 123-131
9 p.
|
artikel
|
| 1266 |
Molecular imaging approaches to facilitate bacteria-mediated cancer therapy
|
Woong Yoo, Su
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1267 |
Molecular imaging for cancer diagnosis and surgery
|
Hussain, Timon
|
|
2014
|
136-137 |
C |
p. 90-100
11 p.
|
artikel
|
| 1268 |
Molecular imaging for precision medicine
|
Lu, Zheng-Rong
|
|
2017
|
136-137 |
C |
p. 1-2
2 p.
|
artikel
|
| 1269 |
Molecular imaging in stem cell-based therapies of cardiac diseases
|
Li, Xiang
|
|
2017
|
136-137 |
C |
p. 71-88
|
artikel
|
| 1270 |
Molecular imaging nanoprobes for theranostic applications
|
He, Haozhe
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1271 |
Molecular imaging of β-cells: diabetes and beyond
|
Wei, Weijun
|
|
2019
|
136-137 |
C |
p. 16-31
|
artikel
|
| 1272 |
Molecular imaging of diabetes and diabetic complications: Beyond pancreatic β-cell targeting
|
Yang, Jichun
|
|
2019
|
136-137 |
C |
p. 32-50
|
artikel
|
| 1273 |
Molecular imaging of innate immunity and immunotherapy
|
Xia, Wenxi
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1274 |
Molecular imaging of the extracellular matrix in the context of atherosclerosis
|
Reimann, Carolin
|
|
2017
|
136-137 |
C |
p. 49-60
12 p.
|
artikel
|
| 1275 |
Molecular imaging of the tumor microenvironment
|
Zhou, Zhuxian
|
|
2017
|
136-137 |
C |
p. 24-48
25 p.
|
artikel
|
| 1276 |
Molecular inflation, attrition and the rule of five
|
Leeson, Paul D.
|
|
2016
|
136-137 |
C |
p. 22-33
12 p.
|
artikel
|
| 1277 |
Molecular links among non-biodegradable nanoparticles, reactive oxygen species, and autophagy
|
Anozie, Uche C.
|
|
2017
|
136-137 |
C |
p. 65-73
|
artikel
|
| 1278 |
Molecularly targeted nanomedicine enabled by inorganic nanoparticles for atherosclerosis diagnosis and treatment
|
Zhang, Xiuwen
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1279 |
Molecular probes for super-resolution imaging of drug dynamics
|
Fang, Hongbao
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1280 |
Molecular properties associated with transporter-mediated drug disposition
|
Varma, Manthena V.
|
|
2017
|
136-137 |
C |
p. 92-99
8 p.
|
artikel
|
| 1281 |
Molecular targeting of hypoxia in radiotherapy
|
Rey, Sergio
|
|
2017
|
136-137 |
C |
p. 45-62
18 p.
|
artikel
|
| 1282 |
Monitoring kinetic processes of drugs and metabolites: Surface-enhanced Raman spectroscopy
|
Luo, Zhewen
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1283 |
Monocytes as a convergent nanoparticle therapeutic target for cardiovascular diseases
|
Aldarondo, Dasia
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1284 |
MR imaging techniques for nano-pathophysiology and theranostics
|
Bennett, Kevin M.
|
|
2014
|
136-137 |
C |
p. 75-94
20 p.
|
artikel
|
| 1285 |
mRNA – A game changer in regenerative medicine, cell-based therapy and reprogramming strategies
|
Chabanovska, Oleksandra
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1286 |
mRNA: A promising platform for cancer immunotherapy
|
Kong, Byoungjae
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1287 |
mRNA delivery systems for cancer immunotherapy: Lipid nanoparticles and beyond
|
Estapé Senti, Mariona
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1288 |
Mucoadhesive and thermogelling systems for vaginal drug delivery
|
Caramella, Carla M.
|
|
2015
|
136-137 |
C |
p. 39-52
14 p.
|
artikel
|
| 1289 |
Mucosal drug delivery and 3D printing technologies: A focus on special patient populations
|
Karavasili, Christina
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1290 |
Mucus models to evaluate the diffusion of drugs and particles
|
Lock, Jaclyn Y.
|
|
2018
|
136-137 |
C |
p. 34-49
|
artikel
|
| 1291 |
Mucus-producing 3D cell culture models
|
Helena Macedo, Maria
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1292 |
Multifaceted role of phyto-derived polyphenols in nanodrug delivery systems
|
Chen, Zhejie
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1293 |
Multifunctional hybrid graphene oxide for circulating tumor cell isolation and analysis
|
PramaniK, Avijit
|
|
|
136-137 |
C |
p. 21-35
|
artikel
|
| 1294 |
Multifunctional nanobiodevices in medical sciences
|
Onoshima, Daisuke
|
|
2015
|
136-137 |
C |
p. 1-
1 p.
|
artikel
|
| 1295 |
Multifunctional nanoparticles for brain tumor imaging and therapy
|
Cheng, Yu
|
|
2014
|
136-137 |
C |
p. 42-57
16 p.
|
artikel
|
| 1296 |
Multifunctional nanotheranostics for near infrared optical imaging-guided treatment of brain tumors
|
Zhang, Li
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1297 |
Multifunctional peptides for tumor therapy
|
Li, Ke
|
|
|
136-137 |
C |
p. 36-51
|
artikel
|
| 1298 |
Multifunctional plasmonic-magnetic nanoparticles for bioimaging and hyperthermia
|
de la Encarnación, Cristina
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1299 |
Multifunctional quantum dots-based cancer diagnostics and stem cell therapeutics for regenerative medicine
|
Onoshima, Daisuke
|
|
2015
|
136-137 |
C |
p. 2-14
13 p.
|
artikel
|
| 1300 |
Multimodal imaging of gliomas in the context of evolving cellular and molecular therapies
|
Keunen, Olivier
|
|
2014
|
136-137 |
C |
p. 98-115
18 p.
|
artikel
|
| 1301 |
Multimodal stratified imaging of nanovaccines in lymph nodes for improving cancer immunotherapy
|
Tian, Rui
|
|
|
136-137 |
C |
p. 145-160
|
artikel
|
| 1302 |
Multiscale biomechanics and mechanotransduction from liver fibrosis to cancer
|
Li, Ning
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1303 |
Multiscale engineering of brain organoids for disease modeling
|
Xu, Cong
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1304 |
Muscle fibrosis in the soft palate: Delivery of cells, growth factors and anti-fibrotics
|
Von den Hoff, Johannes W.
|
|
2019
|
136-137 |
C |
p. 60-76
|
artikel
|
| 1305 |
Myeloid cell-mediated drug delivery: From nanomedicine to cell therapy
|
Zhang, Fan
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1306 |
Nanoarchitectured two-dimensional layered double hydroxides-based nanocomposites for biomedical applications
|
Kankala, Ranjith Kumar
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1307 |
Nanoassemblies designed for efficient nuclear targeting
|
Skowicki, Michal
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1308 |
Nano-based eye drop: Topical and noninvasive therapy for ocular diseases
|
Wang, Chuhan
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1309 |
Nano-bio interactions: A major principle in the dynamic biological processes of nano-assemblies
|
Liu, Jing
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1310 |
Nano-bio interactions in mRNA nanomedicine: Challenges and opportunities for targeted mRNA delivery
|
Saiding, Qimanguli
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1311 |
Nano-bio interactions of 2D molybdenum disulfide
|
Roy, Shounak
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1312 |
Nanobodies: Robust miniprotein binders in biomedicine
|
Yong Joon Kim, Jeffrey
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1313 |
Nanocarrier-based systems for targeted and site specific therapeutic delivery
|
Majumder, Joydeb
|
|
|
136-137 |
C |
p. 57-77
|
artikel
|
| 1314 |
Nanocarriers address intracellular barriers for efficient drug delivery, overcoming drug resistance, subcellular targeting and controlled release
|
Liu, Jing
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1315 |
Nanocarriers transport across the gastrointestinal barriers: The contribution to oral bioavailability via blood circulation and lymphatic pathway
|
Wang, Ding
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1316 |
Nanocarrier vaccines for SARS-CoV-2
|
Machhi, Jatin
|
|
|
136-137 |
C |
p. 215-239
|
artikel
|
| 1317 |
NanoDDS 2018: Engineering the next wave of nanomedicine and drug delivery systems
|
Sahay, Gaurav
|
|
|
136-137 |
C |
p. 1-2
|
artikel
|
| 1318 |
Nano-delivery to the lung - by inhalation or other routes and why nano when micro is largely sufficient?
|
Forest, Valérie
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1319 |
Nanodevices for studying nano-pathophysiology
|
Cabral, Horacio
|
|
2014
|
136-137 |
C |
p. 35-52
18 p.
|
artikel
|
| 1320 |
Nanodiamond-Based Sensing: A revolution for biosensors in capturing elusive bio-signals in living cells
|
Zhang, Jiahua
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1321 |
Nanoformulation-based sequential combination cancer therapy
|
Shim, Gayong
|
|
2017
|
136-137 |
C |
p. 57-81
25 p.
|
artikel
|
| 1322 |
Nanoformulation properties, characterization, and behavior in complex biological matrices: Challenges and opportunities for brain-targeted drug delivery applications and enhanced translational potential
|
Agrahari, Vibhuti
|
|
|
136-137 |
C |
p. 146-180
|
artikel
|
| 1323 |
Nanoformulations for combination or cascade anticancer therapy
|
Miao, Lei
|
|
2017
|
136-137 |
C |
p. 3-22
20 p.
|
artikel
|
| 1324 |
Nanomaterial-based ophthalmic drug delivery
|
Xie, Guocheng
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1325 |
Nanomaterials and molecular transporters to overcome the bacterial envelope barrier: Towards advanced delivery of antibiotics
|
Santos, Rita S.
|
|
2018
|
136-137 |
C |
p. 28-48
|
artikel
|
| 1326 |
Nanomaterials and nanomaterials-based drug delivery to promote cutaneous wound healing
|
Liu, Tengfei
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1327 |
Nanomechanical testing in drug delivery: Theory, applications, and emerging trends
|
Majumder, Sushmita
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1328 |
Nanomedicine and advanced technologies for burns: Preventing infection and facilitating wound healing
|
Mofazzal Jahromi, Mirza Ali
|
|
2018
|
136-137 |
C |
p. 33-64
|
artikel
|
| 1329 |
Nanomedicine at the crossroads – A quick guide for IVIVC
|
Mast, Marc-Phillip
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1330 |
Nanomedicine-based combination anticancer therapy between nucleic acids and small-molecular drugs
|
Huang, Wei
|
|
2017
|
136-137 |
C |
p. 82-97
16 p.
|
artikel
|
| 1331 |
Nanomedicine-based delivery strategies for nucleic acid gene inhibitors in inflammatory diseases
|
Fattal, Elias
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1332 |
Nanomedicine-based intraperitoneal therapy for the treatment of peritoneal carcinomatosis — Mission possible?
|
Dakwar, George R.
|
|
2017
|
136-137 |
C |
p. 13-24
12 p.
|
artikel
|
| 1333 |
Nanomedicine biointeractions during body trafficking
|
He, Wei
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1334 |
Nanomedicine for brain cancer
|
Quader, Sabina
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1335 |
Nanomedicine for targeting brain Neurodegeneration: Critical barriers and circadian rhythm Considerations
|
Pineiro-Alonso, Laura
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1336 |
Nanomedicine for the treatment of diabetes-associated cardiovascular diseases and fibrosis
|
Luo, Xiao-Min
|
|
|
136-137 |
C |
p. 234-248
|
artikel
|
| 1337 |
Nanomedicine from amphiphilizedprodrugs: Concept and clinical translation
|
Xiang, Jiajia
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1338 |
Nanomedicine in the development of anti-HIV microbicides
|
das Neves, José
|
|
|
136-137 |
C |
p. 57-75
|
artikel
|
| 1339 |
Nanomedicine/materdicine-enabled sonocatalytic therapy
|
Chang, Meiqi
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1340 |
Nanomedicines and gene therapy for the delivery of growth factors to improve perfusion and oxygenation in wound healing
|
Desmet, Céline M.
|
|
|
136-137 |
C |
p. 262-284
|
artikel
|
| 1341 |
Nanomedicines for the topical treatment of vulvovaginal infections: Addressing the challenges of antimicrobial resistance
|
Vanić, Željka
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1342 |
Nanomedicines in the future of pediatric therapy
|
Sosnik, Alejandro
|
|
2014
|
136-137 |
C |
p. 140-161
22 p.
|
artikel
|
| 1343 |
Nanomedicines - Tiny particles and big challenges
|
Marques, Margareth R.C.
|
|
|
136-137 |
C |
p. 23-43
|
artikel
|
| 1344 |
Nanomedicines to treat rare neurological disorders: The case of Krabbe disease
|
Moore, Thomas Lee
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1345 |
Nanomedicine to fight infectious disease
|
Rubey, Kathryn M.
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1346 |
Nanoparticle-based immunotherapeutics: From the properties of nanocores to the differential effects of administration routes
|
Perez-Potti, André
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1347 |
Nanoparticle-based local antimicrobial drug delivery
|
Gao, Weiwei
|
|
|
136-137 |
C |
p. 46-57
|
artikel
|
| 1348 |
Nanoparticle-based therapeutic strategies targeting major clinical challenges in pancreatic cancer treatment
|
Tarannum, Mubin
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1349 |
Nanoparticle biodistribution coefficients: A quantitative approach for understanding the tissue distribution of nanoparticles
|
Kumar, Mokshada
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1350 |
Nanoparticle design considerations for molecular imaging of apoptosis: Diagnostic, prognostic, and therapeutic value
|
Savla, Ronak
|
|
2017
|
136-137 |
C |
p. 122-140
19 p.
|
artikel
|
| 1351 |
Nanoparticle designs for delivery of nucleic acid therapeutics as brain cancer therapies
|
Karlsson, Johan
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1352 |
Nanoparticle enhanced blue light therapy
|
Akasov, Roman
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1353 |
Nanoparticle entry into cells; the cell biology weak link
|
Griffiths, Gareth
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1354 |
Nanoparticle-neutrophils interactions for autoimmune regulation
|
Kupor, Daniel
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1355 |
Nanoparticles and trained immunity: Glimpse into the future
|
Magadán, Susana
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1356 |
Nanoparticles derived from naturally occurring metal chelators for theranostic applications
|
Jung, Wonsik
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1357 |
Nanoparticles for drug delivery to the anterior segment of the eye
|
Janagam, Dileep R.
|
|
2017
|
136-137 |
C |
p. 31-64
|
artikel
|
| 1358 |
Nanoparticles for local delivery of siRNA in lung therapy
|
Kubczak, Małgorzata
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1359 |
Nanoparticles for topical drug delivery: Potential for skin cancer treatment
|
Krishnan, Vinu
|
|
|
136-137 |
C |
p. 87-108
|
artikel
|
| 1360 |
Nanoparticles-mediated ion channels manipulation: From their membrane interactions to bioapplications
|
Huang, Qiwen
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1361 |
Nanoparticles targeting the central circadian clock: Potential applications for neurological disorders
|
Le Meur, Marion
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1362 |
Nanoparticle targeting of anti-cancer drugs that alter intracellular signaling or influence the tumor microenvironment
|
Kanapathipillai, Mathumai
|
|
2014
|
136-137 |
C |
p. 107-118
12 p.
|
artikel
|
| 1363 |
Nanoparticle technology and stem cell therapy team up against neurodegenerative disorders
|
Vissers, Caroline
|
|
|
136-137 |
C |
p. 239-251
|
artikel
|
| 1364 |
Nano-pathophysiology: A novel integrated approach to disease through application of nanotechnology
|
Kano, Mitsunobu R.
|
|
2014
|
136-137 |
C |
p. 1-
1 p.
|
artikel
|
| 1365 |
Nanopharmaceuticals for wound healing – Lost in translation?
|
Ashtikar, Mukul
|
|
|
136-137 |
C |
p. 194-218
|
artikel
|
| 1366 |
Nanoplasmonic sensors for detecting circulating cancer biomarkers
|
Ferhan, Abdul Rahim
|
|
|
136-137 |
C |
p. 48-77
|
artikel
|
| 1367 |
Nanoprecipitation and the “Ouzo effect”: Application to drug delivery devices
|
Lepeltier, Elise
|
|
2014
|
136-137 |
C |
p. 86-97
12 p.
|
artikel
|
| 1368 |
Nanopreparations for organelle-specific delivery in cancer
|
Biswas, Swati
|
|
2014
|
136-137 |
C |
p. 26-41
16 p.
|
artikel
|
| 1369 |
Nanoscale contrast agents: A promising tool for ultrasound imaging and therapy
|
Wang, Jieqiong
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1370 |
Nanoscale MOFs: From synthesis to drug delivery and theranostics applications
|
Ding, Mengli
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1371 |
Nanosensitizer-mediated unique dynamic therapy tactics for effective inhibition of deep tumors
|
Sun, Wenjing
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1372 |
Nano-sized and other improved reporters for magnetic resonance imaging of angiogenesis
|
Crich, Simonetta Geninatti
|
|
2017
|
136-137 |
C |
p. 61-72
|
artikel
|
| 1373 |
Nanostructured DNA for the delivery of therapeutic agents
|
Nishikawa, Makiya
|
|
|
136-137 |
C |
p. 29-36
|
artikel
|
| 1374 |
Nanotechnologies for the delivery of biologicals: Historical perspective and current landscape
|
Durán-Lobato, Matilde
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1375 |
Nanotechnology and tumor microcirculation
|
Kano, Mitsunobu R.
|
|
2014
|
136-137 |
C |
p. 2-11
10 p.
|
artikel
|
| 1376 |
Nanotechnology approaches in the current therapy of skin cancer
|
Borgheti-Cardoso, Livia Neves
|
|
|
136-137 |
C |
p. 109-136
|
artikel
|
| 1377 |
Nano-technology based carriers for nitrogen-containing bisphosphonates delivery as sensitisers of γδ T cells for anticancer immunotherapy
|
Hodgins, Naomi O.
|
|
2017
|
136-137 |
C |
p. 143-160
|
artikel
|
| 1378 |
Nanotechnology-based delivery of CRISPR/Cas9 for cancer treatment
|
Xu, Xiaoyu
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1379 |
Nanotechnology-empowered vaccine delivery for enhancing CD8+ T cells-mediated cellular immunity
|
Liu, Guangna
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1380 |
Nanotechnology enabled regenerative medicine for neurological disorders
|
Lowe, Tao L.
|
|
|
136-137 |
C |
p. 1-2
|
artikel
|
| 1381 |
Nanotechnology enabling the use of circulating tumor cells (CTCs) as reliable cancer biomarkers
|
Hong, Seungpyo
|
|
|
136-137 |
C |
p. 1-2
|
artikel
|
| 1382 |
Nanotechnology in cell replacement therapies for type 1 diabetes
|
Ernst, Alexander U.
|
|
2019
|
136-137 |
C |
p. 116-138
|
artikel
|
| 1383 |
Nanotechnology in peripheral nerve repair and reconstruction
|
Carvalho, Cristiana R.
|
|
|
136-137 |
C |
p. 308-343
|
artikel
|
| 1384 |
Nanotechnology in regenerative ophthalmology
|
Sahle, Fitsum Feleke
|
|
|
136-137 |
C |
p. 290-307
|
artikel
|
| 1385 |
Nanotechnology strategies to address challenges in topical and cellular delivery of siRNAs in skin disease therapy
|
Silvestrini, Ana Vitoria Pupo
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1386 |
Nanotherapeutic treatment of the invasive glioblastoma tumor microenvironment
|
Pandey, Nikhil
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1387 |
Nanovaccines with cell-derived components for cancer immunotherapy
|
Meng, Zhouqi
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1388 |
NanoVelcro rare-cell assays for detection and characterization of circulating tumor cells
|
Jan, Yu Jen
|
|
|
136-137 |
C |
p. 78-93
|
artikel
|
| 1389 |
Native gastrointestinal mucus: Critical features and techniques for studying interactions with drugs, drug carriers, and bacteria
|
Wang, Chia-Ming
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1390 |
Natural killer (NK) cell-based immunotherapies and the many faces of NK cell memory: A look into how nanoparticles enhance NK cell activity
|
Mikelez-Alonso, Idoia
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1391 |
Naturally derived and synthetic scaffolds for skeletal muscle reconstruction
|
Wolf, Matthew T.
|
|
2015
|
136-137 |
C |
p. 208-221
14 p.
|
artikel
|
| 1392 |
Nature-inspired dynamic gene-loaded nanoassemblies for the treatment of brain diseases
|
Ji, Weihong
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1393 |
Navigating cancer therapy induced cardiotoxicity: From pathophysiology to treatment innovations
|
Tetterton-Kellner, Jessica
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1394 |
Navigating the complexities of pancreatic ductal adenocarcinoma: A review on therapeutic models and RAS inhibitors
|
Barrambana, Sara
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1395 |
Navigating the human gastrointestinal tract for oral drug delivery: Uncharted waters and new frontiers
|
Koziolek, Mirko
|
|
2016
|
136-137 |
C |
p. 75-88
14 p.
|
artikel
|
| 1396 |
Navigating the landscape of RNA delivery systems in cardiovascular disease therapeutics
|
Gil-Cabrerizo, Paula
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1397 |
Near-infrared fluorescence imaging in immunotherapy
|
Ji, Yuanyuan
|
|
|
136-137 |
C |
p. 121-134
|
artikel
|
| 1398 |
Near-infrared light-activatable polymeric nanoformulations for combined therapy and imaging of cancer
|
Yue, Xiuli
|
|
2017
|
136-137 |
C |
p. 155-170
16 p.
|
artikel
|
| 1399 |
Neuronanotechnology for brain regeneration
|
Liaw, Kevin
|
|
|
136-137 |
C |
p. 3-18
|
artikel
|
| 1400 |
Neurosurgery at the crossroads of immunology and nanotechnology. New reality in the COVID-19 pandemic
|
Ljubimov, Vladimir A.
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1401 |
Neurotheranostics as personalized medicines
|
Kevadiya, Bhavesh D.
|
|
|
136-137 |
C |
p. 252-289
|
artikel
|
| 1402 |
New agents for the treatment of drug-resistant Mycobacterium tuberculosis
|
Hoagland, Daniel T.
|
|
2016
|
136-137 |
C |
p. 55-72
18 p.
|
artikel
|
| 1403 |
New antifungal strategies: Drug combination and co-delivery
|
Zhu, Ping
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1404 |
New radiotracers for imaging of vascular targets in angiogenesis-related diseases
|
Hong, Hao
|
|
2014
|
136-137 |
C |
p. 2-20
19 p.
|
artikel
|
| 1405 |
New strategies for local treatment of vaginal infections
|
Palmeira-de-Oliveira, Rita
|
|
2015
|
136-137 |
C |
p. 105-122
18 p.
|
artikel
|
| 1406 |
Next generation concepts in dermal delivery, theranostics, and preclinical testing
|
Hedtrich, Sarah
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1407 |
Next generation in vitro tumor models guiding cancer therapy
|
Fong, Eliza Li Shan
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1408 |
Next generation strategies for preventing preterm birth
|
Zierden, Hannah C.
|
|
|
136-137 |
C |
p. 190-209
|
artikel
|
| 1409 |
Non-aqueous formulations in topical ocular drug delivery – A paradigm shift?
|
Agarwal, Priyanka
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1410 |
Non-genetic engineering of cells for drug delivery and cell-based therapy
|
Wang, Qun
|
|
2015
|
136-137 |
C |
p. 125-140
16 p.
|
artikel
|
| 1411 |
Noninvasive transdermal delivery of liposomes by weak electric current
|
Hasan, Mahadi
|
|
|
136-137 |
C |
p. 227-235
|
artikel
|
| 1412 |
Non-spherical micro- and nanoparticles for drug delivery: Progress over 15 years
|
Kapate, Neha
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1413 |
Non-transdermal microneedles for advanced drug delivery
|
Lee, KangJu
|
|
|
136-137 |
C |
p. 41-59
|
artikel
|
| 1414 |
Nonviral cancer gene therapy: Delivery cascade and vector nanoproperty integration
|
Zhou, Zhuxian
|
|
2017
|
136-137 |
C |
p. 115-154
40 p.
|
artikel
|
| 1415 |
Non-viral COVID-19 vaccine delivery systems
|
Park, Kyung Soo
|
|
|
136-137 |
C |
p. 137-151
|
artikel
|
| 1416 |
Non-viral delivery of RNA for therapeutic T cell engineering
|
Berdecka, Dominika
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1417 |
Non-viral nanoparticles for RNA interference: Principles of design and practical guidelines
|
Liu, Zehua
|
|
|
136-137 |
C |
p. 576-612
|
artikel
|
| 1418 |
Non-viral strategies for delivering genome editing enzymes
|
Li, Jie
|
|
|
136-137 |
C |
p. 99-117
|
artikel
|
| 1419 |
Novel adjuvant formulations for delivery of anti-tuberculosis vaccine candidates
|
Agger, Else Marie
|
|
2016
|
136-137 |
C |
p. 73-82
10 p.
|
artikel
|
| 1420 |
Novel antimicrobial agents for combating antibiotic-resistant bacteria
|
Chang, Rachel Yoon Kyung
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1421 |
Novel approaches for managing aged skin and nonmelanoma skin cancer
|
Todorova, Kristina
|
|
|
136-137 |
C |
p. 18-27
|
artikel
|
| 1422 |
Novel Discoveries and Clinical Advancements for Treating Onychomycosis: A Mechanistic Insight
|
Kumar Behera, Jitesh
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1423 |
Novel drug delivery systems for actinides (uranium and plutonium) decontamination agents
|
Fattal, Elias
|
|
2015
|
136-137 |
C |
p. 40-54
15 p.
|
artikel
|
| 1424 |
Novel drug delivery systems for the management of dry eye
|
Nagai, Noriaki
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1425 |
Novel formulations and drug delivery systems to administer biological solids
|
Zhang, Yajie
|
|
|
136-137 |
C |
p. 183-210
|
artikel
|
| 1426 |
Novel strategies for modulating the gut microbiome for cancer therapy
|
Cho, Young Seok
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1427 |
Novel targets for delaying aging: The importance of the liver and advances in drug delivery
|
Hunt, Nicholas J.
|
|
2018
|
136-137 |
C |
p. 39-49
|
artikel
|
| 1428 |
Nuclear imaging approaches facilitating nanomedicine translation
|
Pérez-Medina, Carlos
|
|
|
136-137 |
C |
p. 123-141
|
artikel
|
| 1429 |
Nuclear imaging of liposomal drug delivery systems: A critical review of radiolabelling methods and applications in nanomedicine
|
Man, Francis
|
|
|
136-137 |
C |
p. 134-160
|
artikel
|
| 1430 |
Nucleic acid delivery for therapeutic applications
|
Gupta, Akash
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1431 |
Nucleic acid delivery with extracellular vesicles
|
Schulz-Siegmund, Michaela
|
|
|
136-137 |
C |
p. 89-111
|
artikel
|
| 1432 |
Nucleic acid delivery with microbubbles and ultrasound
|
Rychak, Joshua J.
|
|
2014
|
136-137 |
C |
p. 82-93
12 p.
|
artikel
|
| 1433 |
Nucleic acid nanoparticles (NANPs) as molecular tools to direct desirable and avoid undesirable immunological effects
|
Johnson, M. Brittany
|
|
|
136-137 |
C |
p. 427-438
|
artikel
|
| 1434 |
Nucleic acids delivering nucleic acids
|
Catuogno, Silvia
|
|
2018
|
136-137 |
C |
p. 79-93
|
artikel
|
| 1435 |
Ocular delivery of CRISPR/Cas genome editing components for treatment of eye diseases
|
Yu, Wenhan
|
|
|
136-137 |
C |
p. 181-195
|
artikel
|
| 1436 |
Ocular delivery of proteins and peptides: Challenges and novel formulation approaches
|
Mandal, Abhirup
|
|
2018
|
136-137 |
C |
p. 67-95
|
artikel
|
| 1437 |
Ocular immunosuppressive microenvironment and novel drug delivery for control of uveitis
|
Teabagy, Sean
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1438 |
Ocular therapies with biomacromolecules: From local injection to eyedrop and emerging noninvasive delivery strategies
|
Fan, Xingyan
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1439 |
Ocular translational science: A review of development steps and paths
|
Mann, Brenda K.
|
|
2018
|
136-137 |
C |
p. 195-203
|
artikel
|
| 1440 |
Of devices and drugs – Ingestible bots for diagnosis and therapy
|
Vllasaliu, Driton
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1441 |
“Old Drugs, New Tricks” – Local controlled drug release systems for treatment of degenerative joint disease
|
Tryfonidou, Marianna A.
|
|
|
136-137 |
C |
p. 170-185
|
artikel
|
| 1442 |
Old Drugs, New Tricks – Redefining Therapeutic Strategies For Tissue Regeneration
|
Monaghan, Michael G.
|
|
|
136-137 |
C |
p. 279-280
|
artikel
|
| 1443 |
Omics approaches for the assessment of biological responses to nanoparticles
|
Abdelkader, Yasmin
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1444 |
On the interface between biomaterials and two-dimensional materials for biomedical applications
|
Du, Chunbao
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1445 |
Opening doors with ultrasound and microbubbles: Beating biological barriers to promote drug delivery
|
Deprez, J.
|
|
|
136-137 |
C |
p. 9-36
|
artikel
|
| 1446 |
Ophthalmic gels: Past, present and future
|
Al-Kinani, Ali A.
|
|
2018
|
136-137 |
C |
p. 113-126
|
artikel
|
| 1447 |
Opportunities and challenges for co-delivery nanomedicines based on combination of phytochemicals with chemotherapeutic drugs in cancer treatment
|
Gao, Quan
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1448 |
Opportunities and challenges in combination gene cancer therapy
|
Nastiuk, Kent L.
|
|
2016
|
136-137 |
C |
p. 35-40
6 p.
|
artikel
|
| 1449 |
Opportunities and challenges in commercial pharmaceutical liposome applications
|
Jensen, Gerard M.
|
|
|
136-137 |
C |
p. 2-12
|
artikel
|
| 1450 |
Opportunities and challenges in delivering biologics for Alzheimer’s disease by low-intensity ultrasound
|
Chen, Liyu
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1451 |
Opportunities and delusions regarding drug delivery targeting pancreatic cancer-associated fibroblasts
|
Liu, Huiqin
|
|
|
136-137 |
C |
p. 37-51
|
artikel
|
| 1452 |
Opportunities for improving brain cancer treatment outcomes through imaging-based mathematical modeling of the delivery of radiotherapy and immunotherapy
|
Hormuth II, David A.
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1453 |
Opportunities for milk and milk-related systems as ‘new’ low-cost excipient drug delivery materials
|
Salim, Malinda
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1454 |
Opportunities for new CT contrast agents to maximize the diagnostic potential of emerging spectral CT technologies
|
Yeh, Benjamin M.
|
|
2017
|
136-137 |
C |
p. 201-222
22 p.
|
artikel
|
| 1455 |
Optical clearing of tissues: Issues of antimicrobial phototherapy and drug delivery
|
Tuchin, Valery V.
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1456 |
Optical coherence tomography for noninvasive monitoring of drug delivery
|
Aglyamov, Salavat R.
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1457 |
Optical properties of natural small molecules and their applications in imaging and nanomedicine
|
Yuan, Hao
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1458 |
Optimizing Advances in Nanoparticle Delivery for Cancer Immunotherapy
|
Caster, Joseph M.
|
|
|
136-137 |
C |
p. 3-15
|
artikel
|
| 1459 |
Optimizing synthetic nucleic acid and protein nanocarriers: The chemical evolution approach
|
Freitag, Franziska
|
|
|
136-137 |
C |
p. 30-54
|
artikel
|
| 1460 |
Oral delivery of macromolecular drugs: Where we are after almost 100years of attempts
|
Moroz, Elena
|
|
2016
|
136-137 |
C |
p. 108-121
14 p.
|
artikel
|
| 1461 |
Oral delivery of natural active small molecules by polymeric nanoparticles for the treatment of inflammatory bowel diseases
|
Zu, Menghang
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1462 |
Oral delivery of peptide therapeutics in infants: Challenges and opportunities
|
Gleeson, John P.
|
|
|
136-137 |
C |
p. 112-124
|
artikel
|
| 1463 |
Oral delivery of therapeutic peptides and proteins: Technology landscape of lipid-based nanocarriers
|
Haddadzadegan, Soheil
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1464 |
Oral drug delivery strategies for development of poorly water soluble drugs in paediatric patient population
|
Salunke, Smita
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1465 |
Oral lipid nanomedicines: Current status and future perspectives in cancer treatment
|
El Moukhtari, Souhaila H.
|
|
|
136-137 |
C |
p. 238-251
|
artikel
|
| 1466 |
Orally ingestible medical devices for gut engineering
|
Mandsberg, Nikolaj Kofoed
|
|
|
136-137 |
C |
p. 142-154
|
artikel
|
| 1467 |
Orally inhaled migraine therapy: Where are we now?
|
Stapleton, Kevin W.
|
|
2018
|
136-137 |
C |
p. 131-134
|
artikel
|
| 1468 |
Oral nanomedicine biointeractions in the gastrointestinal tract in health and disease
|
Chen, Cheng
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1469 |
Oral nanomedicine for modulating immunity, intestinal barrier functions, and gut microbiome
|
Lee, Yonghyun
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1470 |
Oral transmucosal drug delivery for pediatric use
|
Lam, Jenny K.W.
|
|
2014
|
136-137 |
C |
p. 50-62
13 p.
|
artikel
|
| 1471 |
Organ-on-a-chip technology for the study of the female reproductive system
|
Young, Rachel E.
|
|
|
136-137 |
C |
p. 461-478
|
artikel
|
| 1472 |
Organ-specific endothelial cell heterogenicity and its impact on regenerative medicine and biomedical engineering applications
|
Urbanczyk, Max
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1473 |
Orodispersible films: Conception to quality by design
|
Gupta, Maram Suresh
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1474 |
Overcoming barriers by local drug delivery with liposomes
|
Antimisiaris, S.G.
|
|
|
136-137 |
C |
p. 53-86
|
artikel
|
| 1475 |
Overcoming biological barriers by virus-like drug particles for drug delivery
|
Chen, Yu-Ling
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1476 |
Overcoming ocular drug delivery barriers through the use of physical forces
|
Huang, Di
|
|
2018
|
136-137 |
C |
p. 96-112
|
artikel
|
| 1477 |
Overcoming therapy resistance in pancreatic cancer: challenges and emerging strategies
|
du Toit-Thompson, Taymin
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1478 |
Overcoming the rising incidence and evolving mechanisms of antibiotic resistance by novel drug delivery approaches – An overview
|
Lai, Christopher K.C.
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1479 |
Oxygenation strategies for encapsulated islet and beta cell transplants
|
Papas, Klearchos K.
|
|
2019
|
136-137 |
C |
p. 139-156
|
artikel
|
| 1480 |
Oxygen supply to encapsulated therapeutic cells
|
Colton, Clark K.
|
|
2014
|
136-137 |
C |
p. 93-110
18 p.
|
artikel
|
| 1481 |
Paediatric drug delivery
|
Nunn, Anthony
|
|
2014
|
136-137 |
C |
p. 1-
1 p.
|
artikel
|
| 1482 |
Paediatric drug development: The impact of evolving regulations
|
Turner, M.A.
|
|
2014
|
136-137 |
C |
p. 2-13
12 p.
|
artikel
|
| 1483 |
Paediatric oral biopharmaceutics: Key considerations and current challenges
|
Batchelor, Hannah K.
|
|
2014
|
136-137 |
C |
p. 102-126
25 p.
|
artikel
|
| 1484 |
Pancreatic organoids as cancer avatars for true personalized medicine
|
Gout, Johann
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1485 |
Parallel evolution of polymer chemistry and immunology: Integrating mechanistic biology with materials design
|
Sadtler, Kaitlyn
|
|
|
136-137 |
C |
p. 65-79
|
artikel
|
| 1486 |
Parenteral emulsions and liposomes to treat drug overdose
|
Damitz, Robert
|
|
2015
|
136-137 |
C |
p. 12-23
12 p.
|
artikel
|
| 1487 |
Particle engineering principles and technologies for pharmaceutical biologics
|
Cun, Dongmei
|
|
|
136-137 |
C |
p. 140-167
|
artikel
|
| 1488 |
Particle tracking in drug and gene delivery research: State-of-the-art applications and methods
|
Schuster, Benjamin S.
|
|
2015
|
136-137 |
C |
p. 70-91
22 p.
|
artikel
|
| 1489 |
Pathogenic fungi: Novel targets and theranostic strategies
|
Wang, Yue
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1490 |
Pathophysiological communication between hepatocytes and non-parenchymal cells in liver injury from NAFLD to liver fibrosis
|
Kumar, Santosh
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1491 |
Pathophysiology of liver fibrosis and the methodological barriers to the development of anti-fibrogenic agents
|
Böttcher, Katrin
|
|
2017
|
136-137 |
C |
p. 3-8
|
artikel
|
| 1492 |
Patient-derived xenograft models of BRCA-associated pancreatic cancers
|
Golan, Talia
|
|
|
136-137 |
C |
p. 257-265
|
artikel
|
| 1493 |
Paving the way for bacteria-based drug delivery: biohybrid microrobots emerging from microrobotics and synthetic biology
|
Totter, Elena
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1494 |
PDGF receptors in tumor stroma: Biological effects and associations with prognosis and response to treatment
|
Östman, Arne
|
|
2017
|
136-137 |
C |
p. 117-123
|
artikel
|
| 1495 |
PEGylation for enhancing nanoparticle diffusion in mucus
|
Huckaby, Justin T.
|
|
2018
|
136-137 |
C |
p. 125-139
|
artikel
|
| 1496 |
Penetration and translocation of functional inorganic nanomaterials into biological barriers
|
Cong, Yalin
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1497 |
Peptide and peptide-based inhibitors of SARS-CoV-2 entry
|
Schütz, Desiree
|
|
|
136-137 |
C |
p. 47-65
|
artikel
|
| 1498 |
Peptide-based imaging agents for cancer detection
|
Sun, Xiaolian
|
|
2017
|
136-137 |
C |
p. 38-51
14 p.
|
artikel
|
| 1499 |
Peptide-based strategies for enhanced cell uptake, transcellular transport, and circulation: Mechanisms and challenges
|
Komin, A.
|
|
2017
|
136-137 |
C |
p. 52-64
13 p.
|
artikel
|
| 1500 |
Peptide-based supramolecular hydrogels for local drug delivery
|
Zhang, Zhenghao
|
|
|
136-137 |
C |
p. 482-503
|
artikel
|
| 1501 |
Peptide-containing nanoformulations: Skin barrier penetration and activity contribution
|
Zhang, Tingting
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1502 |
Peptide-decorated nanocarriers penetrating the blood-brain barrier for imaging and therapy of brain diseases
|
Gao, Xihui
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1503 |
Peptide–drug conjugates as effective prodrug strategies for targeted delivery
|
Wang, Yin
|
|
2017
|
136-137 |
C |
p. 112-126
15 p.
|
artikel
|
| 1504 |
Peptide ligand-modified nanomedicines for targeting cells at the tumor microenvironment
|
David, Ayelet
|
|
2017
|
136-137 |
C |
p. 120-142
|
artikel
|
| 1505 |
Peptides and Peptide Conjugates in Medicine
|
Cui, Honggang
|
|
2017
|
136-137 |
C |
p. 1-2
2 p.
|
artikel
|
| 1506 |
Peripheral nerve regeneration: Experimental strategies and future perspectives
|
Faroni, Alessandro
|
|
2015
|
136-137 |
C |
p. 160-167
8 p.
|
artikel
|
| 1507 |
Perspectives on the amorphisation/milling relationship in pharmaceutical materials
|
Descamps, M.
|
|
2016
|
136-137 |
C |
p. 51-66
16 p.
|
artikel
|
| 1508 |
Perspectives on the past, present, and future of cancer nanomedicine
|
Youn, Yu Seok
|
|
2018
|
136-137 |
C |
p. 3-11
|
artikel
|
| 1509 |
Phage-based vaccines
|
Bao, Qing
|
|
2019
|
136-137 |
C |
p. 40-56
|
artikel
|
| 1510 |
Phage therapy for respiratory infections
|
Chang, Rachel Yoon Kyung
|
|
2018
|
136-137 |
C |
p. 76-86
|
artikel
|
| 1511 |
Pharmaceutical and biotech industry perspectives on optimizing patient experience and treatment adherence through subcutaneous drug delivery design
|
Stevenson, Jennifer
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1512 |
Pharmaceutical applications of a nanospectroscopic technique: Surface-enhanced Raman spectroscopy
|
Yilmaz, Hulya
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1513 |
Pharmaceutical applications of powder-based binder jet 3D printing process – A review
|
Sen, Koyel
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1514 |
Pharmaceutical aspects of salt and cocrystal forms of APIs and characterization challenges
|
Cerreia Vioglio, Paolo
|
|
2017
|
136-137 |
C |
p. 86-110
25 p.
|
artikel
|
| 1515 |
Pharmaceutical cocrystals, salts and multicomponent systems; intermolecular interactions and property based design
|
Berry, David J.
|
|
2017
|
136-137 |
C |
p. 3-24
22 p.
|
artikel
|
| 1516 |
Pharmaceutical cocrystals, salts and polymorphs: Advanced characterization techniques
|
Pindelska, Edyta
|
|
2017
|
136-137 |
C |
p. 111-146
36 p.
|
artikel
|
| 1517 |
Pharmaceutical electrospinning and 3D printing scaffold design for bone regeneration
|
Wang, Zhen
|
|
|
136-137 |
C |
p. 504-534
|
artikel
|
| 1518 |
Pharmaceutical protein solids: Drying technology, solid-state characterization and stability
|
Chen, Yuan
|
|
|
136-137 |
C |
p. 211-233
|
artikel
|
| 1519 |
Pharmaceutical solvates, hydrates and amorphous forms: A special emphasis on cocrystals
|
Healy, Anne Marie
|
|
2017
|
136-137 |
C |
p. 25-46
22 p.
|
artikel
|
| 1520 |
Pharmacokinetic and pharmacodynamic implications in inhalable antimicrobial therapy
|
Mukker, Jatinder Kaur
|
|
2015
|
136-137 |
C |
p. 57-64
8 p.
|
artikel
|
| 1521 |
Pharmacokinetic/pharmacodynamic modelling approaches in paediatric infectious diseases and immunology
|
Barker, Charlotte I.S.
|
|
2014
|
136-137 |
C |
p. 127-139
13 p.
|
artikel
|
| 1522 |
Pharmacokinetics and biodistribution of recently-developed siRNA nanomedicines
|
Park, Jinho
|
|
2016
|
136-137 |
C |
p. 93-109
17 p.
|
artikel
|
| 1523 |
Pharmacokinetics and pharmacodynamics of peptide antibiotics
|
Bian, Xingchen
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1524 |
Pharmacokinetics, biodistribution and cell uptake of antisense oligonucleotides
|
Geary, Richard S.
|
|
2015
|
136-137 |
C |
p. 46-51
6 p.
|
artikel
|
| 1525 |
Pharmacokinetics of nanotechnology-based formulations in pediatric populations
|
Yellepeddi, Venkata K.
|
|
|
136-137 |
C |
p. 44-55
|
artikel
|
| 1526 |
Pharmacokinetics, pharmacodynamics and safety of aptamers
|
Kovacevic, Katarina D.
|
|
2018
|
136-137 |
C |
p. 36-50
|
artikel
|
| 1527 |
Pharmacological and physical vessel modulation strategies to improve EPR-mediated drug targeting to tumors
|
Ojha, Tarun
|
|
2017
|
136-137 |
C |
p. 44-60
|
artikel
|
| 1528 |
Photodynamic and antibiotic therapy in combination against bacterial infections: efficacy, determinants, mechanisms, and future perspectives
|
Feng, Yanfang
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1529 |
Photomedicine based on heme-derived compounds
|
Keum, Hyeongseop
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1530 |
Photonic and magnetic materials for on-demand local drug delivery
|
Armenia, Ilaria
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1531 |
Phototheranostics for multifunctional treatment of cancer with fluorescence imaging
|
Yin, Xiaoran
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1532 |
Phototherapy and optical waveguides for the treatment of infection
|
Wang, Dingbowen
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1533 |
Photo-triggered polymer nanomedicines: From molecular mechanisms to therapeutic applications
|
Beauté, Louis
|
|
2019
|
136-137 |
C |
p. 148-166
|
artikel
|
| 1534 |
Physical and chemical profiles of nanoparticles for lymphatic targeting
|
Ke, Xiyu
|
|
|
136-137 |
C |
p. 72-93
|
artikel
|
| 1535 |
Physical and mechanical properties of PLA, and their functions in widespread applications — A comprehensive review
|
Farah, Shady
|
|
2016
|
136-137 |
C |
p. 367-392
|
artikel
|
| 1536 |
Physical chemistry of supersaturated solutions and implications for oral absorption
|
Taylor, Lynne S.
|
|
2016
|
136-137 |
C |
p. 122-142
21 p.
|
artikel
|
| 1537 |
Physical drug delivery enhancement for aged skin, UV damaged skin and skin cancer: Translation and commercialization
|
Yamada, Miko
|
|
|
136-137 |
C |
p. 2-17
|
artikel
|
| 1538 |
Physical energy for drug delivery; poration, concentration and activation
|
Lakshmanan, Shanmugamurthy
|
|
2014
|
136-137 |
C |
p. 98-114
17 p.
|
artikel
|
| 1539 |
Physically-triggered nanosystems based on two-dimensional materials for cancer theranostics
|
Ji, Ding-Kun
|
|
2019
|
136-137 |
C |
p. 211-232
|
artikel
|
| 1540 |
Physically-triggered nanosystems for therapy and diagnosis
|
Wilhelm, Claire
|
|
2019
|
136-137 |
C |
p. 1-2
|
artikel
|
| 1541 |
Physical methods for enhancing drug absorption from the gastrointestinal tract
|
Luo, Zhi
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1542 |
Physical stimuli-responsive vesicles in drug delivery: Beyond liposomes and polymersomes
|
Kauscher, Ulrike
|
|
2019
|
136-137 |
C |
p. 259-275
|
artikel
|
| 1543 |
Physical triggering strategies for drug delivery
|
Sun, Tao
|
|
|
136-137 |
C |
p. 36-62
|
artikel
|
| 1544 |
Physiologically based pharmacokinetic modelling to guide drug delivery in older people
|
Chetty, Manoranjenni
|
|
2018
|
136-137 |
C |
p. 85-96
|
artikel
|
| 1545 |
Physiological models for in vivo imaging and targeting the lymphatic system: Nanoparticles and extracellular vesicles
|
Olmeda, David
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1546 |
Phytonanomaterials as therapeutic agents and drug delivery carriers
|
Xie, Ying
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1547 |
Placental control of drug delivery
|
Al-Enazy, Sanaalarab
|
|
2017
|
136-137 |
C |
p. 63-72
10 p.
|
artikel
|
| 1548 |
PLA composites: From production to properties
|
Murariu, Marius
|
|
2016
|
136-137 |
C |
p. 17-46
|
artikel
|
| 1549 |
PLA micro- and nano-particles
|
Lee, Byung Kook
|
|
2016
|
136-137 |
C |
p. 176-191
|
artikel
|
| 1550 |
Plant-derived nanotherapeutic systems to counter the overgrowing threat of resistant microbes and biofilms
|
Asghar, Sajid
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1551 |
Plant virus-based materials for biomedical applications: Trends and prospects
|
Eiben, Sabine
|
|
2019
|
136-137 |
C |
p. 96-118
|
artikel
|
| 1552 |
Playing hide and seek with poorly tasting paediatric medicines: Do not forget the excipients
|
Walsh, Jennifer
|
|
2014
|
136-137 |
C |
p. 14-33
20 p.
|
artikel
|
| 1553 |
Point-, line-, and plane-shaped cellular constructs for 3D tissue assembly
|
Morimoto, Yuya
|
|
2015
|
136-137 |
C |
p. 29-39
11 p.
|
artikel
|
| 1554 |
Poly(α-hydroxy acid)s and poly(α-hydroxy acid-co-α-amino acid)s derived from amino acid
|
Basu, Arijit
|
|
2016
|
136-137 |
C |
p. 82-96
|
artikel
|
| 1555 |
Poly (lactic acid)-based biomaterials for orthopaedic regenerative engineering
|
Narayanan, Ganesh
|
|
2016
|
136-137 |
C |
p. 247-276
|
artikel
|
| 1556 |
Poly(lactic acid) based hydrogels
|
Basu, Arijit
|
|
2016
|
136-137 |
C |
p. 192-205
|
artikel
|
| 1557 |
Poly(lactic acid) blends in biomedical applications
|
Saini, P.
|
|
2016
|
136-137 |
C |
p. 47-59
|
artikel
|
| 1558 |
Poly(lactic acid) for delivery of bioactive macromolecules
|
James, Roshan
|
|
2016
|
136-137 |
C |
p. 277-288
|
artikel
|
| 1559 |
Poly(lactic acid)—Mass production, processing, industrial applications, and end of life
|
Castro-Aguirre, E.
|
|
2016
|
136-137 |
C |
p. 333-366
|
artikel
|
| 1560 |
Poly(lactic acid) nanofibrous scaffolds for tissue engineering
|
Santoro, Marco
|
|
2016
|
136-137 |
C |
p. 206-212
|
artikel
|
| 1561 |
Polylactic acid (PLA) controlled delivery carriers for biomedical applications
|
Tyler, Betty
|
|
2016
|
136-137 |
C |
p. 163-175
|
artikel
|
| 1562 |
Poly(lactic acid) stereocomplexes: A decade of progress
|
Tsuji, Hideto
|
|
2016
|
136-137 |
C |
p. 97-135
|
artikel
|
| 1563 |
Polylactides in additive biomanufacturing
|
Poh, Patrina S.P.
|
|
2016
|
136-137 |
C |
p. 228-246
|
artikel
|
| 1564 |
Polylactides—Methods of synthesis and characterization
|
Pretula, Julia
|
|
2016
|
136-137 |
C |
p. 3-16
|
artikel
|
| 1565 |
Polymer- and lipid-based nanocarriers for ocular drug delivery: Current status and future perspectives
|
Han, Haijie
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1566 |
Polymer antidotes for toxin sequestration
|
Weisman, Adam
|
|
2015
|
136-137 |
C |
p. 81-100
20 p.
|
artikel
|
| 1567 |
Polymer-based drug delivery systems under investigation for enzyme replacement and other therapies of lysosomal storage disorders
|
Placci, Marina
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1568 |
Polymer-based nanocarriers for vaginal drug delivery
|
das Neves, José
|
|
2015
|
136-137 |
C |
p. 53-70
18 p.
|
artikel
|
| 1569 |
Polymer based sustained drug delivery to the ocular posterior segment: barriers and future opportunities for the treatment of neovascular pathologies
|
Alshaikh, Rasha A.
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1570 |
Polymeric carriers for enhanced delivery of probiotics
|
Asgari, Shadi
|
|
|
136-137 |
C |
p. 1-21
|
artikel
|
| 1571 |
Polymeric drug delivery systems by additive manufacturing
|
Borandeh, Sedigheh
|
|
|
136-137 |
C |
p. 349-373
|
artikel
|
| 1572 |
Polymeric in situ forming depots for long-acting drug delivery systems
|
Pandya, Anjali K.
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1573 |
Polymeric long-acting drug delivery systems (LADDS) for treatment of chronic diseases: Inserts, patches, wafers, and implants
|
Abdelkader, Hamdy
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1574 |
Polymeric micelles for the delivery of poorly soluble drugs: From nanoformulation to clinical approval
|
Hwang, Duhyeong
|
|
|
136-137 |
C |
p. 80-118
|
artikel
|
| 1575 |
Polymeric microneedles for transdermal protein delivery
|
Ye, Yanqi
|
|
|
136-137 |
C |
p. 106-118
|
artikel
|
| 1576 |
Polymeric nano- and microparticulate drug delivery systems for treatment of biofilms
|
Birk, Stine Egebro
|
|
|
136-137 |
C |
p. 30-52
|
artikel
|
| 1577 |
Polymeric vehicles for nucleic acid delivery
|
Piotrowski-Daspit, Alexandra S.
|
|
|
136-137 |
C |
p. 119-132
|
artikel
|
| 1578 |
Polymer nanomedicines
|
Kopeček, Jindřich
|
|
|
136-137 |
C |
p. 40-64
|
artikel
|
| 1579 |
Polymers in cell encapsulation from an enveloped cell perspective
|
de Vos, Paul
|
|
2014
|
136-137 |
C |
p. 15-34
20 p.
|
artikel
|
| 1580 |
Polymers in pharmaceutical additive manufacturing: A balancing act between printability and product performance
|
Govender, Rydvikha
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1581 |
Polymorphic phase transitions: Macroscopic theory and molecular simulation
|
Anwar, Jamshed
|
|
2017
|
136-137 |
C |
p. 47-70
24 p.
|
artikel
|
| 1582 |
Polypharmacology approaches for brain disorders aimed to enhance brain permeability and circadian clock targeting
|
Kampasis, Dionysis
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1583 |
Polyplex designs for improving the stability and safety of RNA therapeutics
|
Uchida, Satoshi
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1584 |
Polysaccharide hydrogel platforms as suitable carriers of liposomes and extracellular vesicles for dermal applications
|
Pourtalebi Jahromi, Leila
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1585 |
Porcine genome engineering for xenotransplantation
|
Niu, Dong
|
|
|
136-137 |
C |
p. 229-245
|
artikel
|
| 1586 |
Positron emission tomography and nanotechnology: A dynamic duo for cancer theranostics
|
Goel, Shreya
|
|
2017
|
136-137 |
C |
p. 157-176
20 p.
|
artikel
|
| 1587 |
Post-inhalation cough with therapeutic aerosols: Formulation considerations
|
Sahakijpijarn, Sawittree
|
|
|
136-137 |
C |
p. 127-141
|
artikel
|
| 1588 |
Potential and development of inhaled RNAi therapeutics for the treatment of pulmonary tuberculosis
|
Man, Dede K.W.
|
|
2016
|
136-137 |
C |
p. 21-32
12 p.
|
artikel
|
| 1589 |
Potential of stem cell treatment in detrusor dysfunction
|
Andersson, Karl-Erik
|
|
2015
|
136-137 |
C |
p. 117-122
6 p.
|
artikel
|
| 1590 |
Potentials of ionic liquids to overcome physical and biological barriers
|
Beaven, Elfa
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1591 |
Power of mitochondrial drug delivery systems to produce innovative nanomedicines
|
Yamada, Yuma
|
|
|
136-137 |
C |
p. 187-209
|
artikel
|
| 1592 |
Practical guidelines for the characterization and quality control of pure drug nanoparticles and nano-cocrystals in the pharmaceutical industry
|
Peltonen, Leena
|
|
2018
|
136-137 |
C |
p. 101-115
|
artikel
|
| 1593 |
Precise subcellular targeting approaches for organelle-related disorders
|
Shim, Gayong
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1594 |
Precision monitoring of immunotherapies in solid organ and hematopoietic stem cell transplantation
|
DiLoreto, Rose
|
|
2017
|
136-137 |
C |
p. 272-284
|
artikel
|
| 1595 |
Preclinical and clinical development of siRNA-based therapeutics
|
Ozcan, Gulnihal
|
|
2015
|
136-137 |
C |
p. 108-119
12 p.
|
artikel
|
| 1596 |
Preclinical assessments of vaginal microbicide candidate safety and efficacy
|
Fernández-Romero, José A.
|
|
2015
|
136-137 |
C |
p. 27-38
12 p.
|
artikel
|
| 1597 |
Preclinical models and technologies to advance nanovaccine development
|
Peres, Carina
|
|
|
136-137 |
C |
p. 148-182
|
artikel
|
| 1598 |
Preclinical safety and efficacy models for pulmonary drug delivery of antimicrobials with focus on in vitro models
|
Hittinger, Marius
|
|
2015
|
136-137 |
C |
p. 44-56
13 p.
|
artikel
|
| 1599 |
Preclinical testing of drug delivery systems to bone
|
van Griensven, Martijn
|
|
2015
|
136-137 |
C |
p. 151-164
14 p.
|
artikel
|
| 1600 |
Predicting bioavailability of monoclonal antibodies after subcutaneous administration: Open innovation challenge
|
Sánchez-Félix, Manuel
|
|
|
136-137 |
C |
p. 66-77
|
artikel
|
| 1601 |
Prediction of cytochrome P450 mediated metabolism
|
Olsen, Lars
|
|
2015
|
136-137 |
C |
p. 61-71
11 p.
|
artikel
|
| 1602 |
Prediction of drug–ABC-transporter interaction — Recent advances and future challenges
|
Montanari, Floriane
|
|
2015
|
136-137 |
C |
p. 17-26
10 p.
|
artikel
|
| 1603 |
Preface
|
Juliano, R.L.
|
|
2015
|
136-137 |
C |
p. 1-2
2 p.
|
artikel
|
| 1604 |
Preface
|
Ghandehari, Hamid
|
|
2014
|
136-137 |
C |
p. 1-
1 p.
|
artikel
|
| 1605 |
Preface
|
Thiagarajan, Giridhar
|
|
2017
|
136-137 |
C |
p. 1-
1 p.
|
artikel
|
| 1606 |
Preface
|
Bunt, Craig
|
|
2018
|
136-137 |
C |
p. 1-2
|
artikel
|
| 1607 |
Preface: Additive manufacturing in pharmaceutical product design
|
Rantanen, Jukka
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1608 |
Preface: A new era of RNA-based therapies
|
Hwa Kim, Sun
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1609 |
Preface: Engineering of pharmaceutical cocrystals, salts and polymorphs: Advances and Challenges
|
Douroumis, Dennis
|
|
2017
|
136-137 |
C |
p. 1-2
2 p.
|
artikel
|
| 1610 |
Preface: Image-assisted organoid research and application
|
Yoo, Hyuk Sang
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1611 |
Preface in special theme: Functional inorganic nanomaterials for cutting-edge theranostic applications
|
Xing, Bengang
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1612 |
Preface: Molecular Mechanisms, Novel Modes of Regulation, and Therapeutic Strategies
|
You, Guofeng
|
|
2017
|
136-137 |
C |
p. 1-2
2 p.
|
artikel
|
| 1613 |
Preface: Nanoformulations for combination or cascade anticancer therapy
|
Zhang, Qiang
|
|
2017
|
136-137 |
C |
p. 1-2
2 p.
|
artikel
|
| 1614 |
Preface: Pharmaceutical applications of Raman spectroscopy — From diagnosis to therapeutics
|
Popp, Jürgen
|
|
2015
|
136-137 |
C |
p. 1-2
2 p.
|
artikel
|
| 1615 |
Preface: Phyto-derived nanomedicines for therapeutics, imaging and drug delivery
|
Qiao, Hongzhi
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1616 |
Preface: The engineering behind a dry powder inhaler: From experiments to computations
|
Kourmatzis, Agisilaos
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1617 |
Prevention of diabetes-associated fibrosis: Strategies in FcRn-targeted nanosystems for oral drug delivery
|
Azevedo, Cláudia
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1618 |
Principles and applications of sono-optogenetics
|
Yang, Fan
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1619 |
Probing organoid metabolism using fluorescence lifetime imaging microscopy (FLIM): The next frontier of drug discovery and disease understanding
|
Barroso, Margarida
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1620 |
Probing the relevance of 3D cancer models in nanomedicine research
|
Leong, David T.
|
|
2014
|
136-137 |
C |
p. 95-106
12 p.
|
artikel
|
| 1621 |
Probiotic engineering strategies for the heterologous production of antimicrobial peptides
|
Mejía-Pitta, Adriana
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1622 |
Prodrug approaches for the development of a long-acting drug delivery systems
|
Chien, Shin-Tian
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1623 |
Prodrugs in medicinal chemistry and enzyme prodrug therapies
|
Walther, Raoul
|
|
2017
|
136-137 |
C |
p. 65-77
|
artikel
|
| 1624 |
Production of pure drug nanocrystals and nano co-crystals by confinement methods
|
Fontana, Flavia
|
|
2018
|
136-137 |
C |
p. 3-21
|
artikel
|
| 1625 |
Profiles and technological requirements of urogenital probiotics
|
Nader-Macías, María Elena Fátima
|
|
2015
|
136-137 |
C |
p. 84-104
21 p.
|
artikel
|
| 1626 |
Programmability and biomedical utility of intrinsically-disordered protein polymers
|
Giraldo-Castaño, Maria Camila
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1627 |
Progress and challenges towards CRISPR/Cas clinical translation
|
Rosenblum, Daniel
|
|
|
136-137 |
C |
p. 176-186
|
artikel
|
| 1628 |
Progress and opportunities for enhancing the delivery and efficacy of checkpoint inhibitors for cancer immunotherapy
|
Francis, David M.
|
|
2017
|
136-137 |
C |
p. 33-42
|
artikel
|
| 1629 |
Progress in cell-based therapies for tendon repair
|
Gaspar, Diana
|
|
2015
|
136-137 |
C |
p. 240-256
17 p.
|
artikel
|
| 1630 |
Progress in tumor-associated macrophage (TAM)-targeted therapeutics
|
Ngambenjawong, Chayanon
|
|
2017
|
136-137 |
C |
p. 206-221
|
artikel
|
| 1631 |
Progress, obstacles, and limitations in the use of stem cells in organ-on-a-chip models
|
Wnorowski, Alexa
|
|
2019
|
136-137 |
C |
p. 3-11
|
artikel
|
| 1632 |
Progress of engineered bacteria for tumor therapy
|
Fan, Jin-Xuan
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1633 |
Progress of tumor-resident intracellular bacteria for cancer therapy
|
Bao, Peng
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1634 |
Progress on the pathological tissue microenvironment barrier-modulated nanomedicine
|
Han, Han
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1635 |
Prophylactic vaccine delivery systems against epidemic infectious diseases
|
Pan, Chao
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1636 |
Prospects of coupled iron-based nanostructures in preclinical antibacterial therapy
|
Han, Jingjing
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1637 |
Prospects of magnetically based approaches addressing inflammation in tendon tissues
|
Vinhas, Adriana
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1638 |
Proteases in cancer drug delivery
|
Vandooren, Jennifer
|
|
2016
|
136-137 |
C |
p. 144-155
12 p.
|
artikel
|
| 1639 |
Protein and polypeptide mediated delivery to the eye
|
Attia, Sara Aly
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1640 |
Protein corona: Friend or foe? Co-opting serum proteins for nanoparticle delivery
|
Kim, Woojun
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1641 |
Protein encapsulation of nanocatalysts: A feasible approach to facilitate catalytic theranostics
|
Jin, Duo
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1642 |
Protein-engineered biomaterials for cartilage therapeutics and repair
|
Haq-Siddiqi, Nada A.
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1643 |
Protein stability — An underappreciated but critical need for drug delivery systems
|
Cicerone, Marcus
|
|
2015
|
136-137 |
C |
p. 1-
1 p.
|
artikel
|
| 1644 |
Protein stability in pulmonary drug delivery via nebulization
|
Hertel, Sebastian P.
|
|
2015
|
136-137 |
C |
p. 79-94
16 p.
|
artikel
|
| 1645 |
Proton therapy – Present and future
|
Mohan, Radhe
|
|
2017
|
136-137 |
C |
p. 26-44
19 p.
|
artikel
|
| 1646 |
Publisher’s note
|
|
|
|
136-137 |
C |
p. 1
|
artikel
|
| 1647 |
Publisher’s note
|
|
|
|
136-137 |
C |
p. 1
|
artikel
|
| 1648 |
Publisher’s Note: Thank you Prof Hamid Ghandehari
|
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1649 |
Pulmonary delivery nanomedicines towards circumventing physiological barriers: Strategies and characterization approaches
|
Wang, Wenhao
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1650 |
Pulmonary drug delivery to older people
|
Wallin, Martin
|
|
2018
|
136-137 |
C |
p. 50-61
|
artikel
|
| 1651 |
Purified mucins in drug delivery research
|
Marczynski, Matthias
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1652 |
Radiation-assisted strategies provide new perspectives to improve the nanoparticle delivery to tumor
|
Zhang, Dongxiao
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1653 |
Radiation effects on the tumor microenvironment: Implications for nanomedicine delivery
|
Stapleton, Shawn
|
|
2017
|
136-137 |
C |
p. 119-130
12 p.
|
artikel
|
| 1654 |
Radioimmunotherapy of cancer with high linear energy transfer (LET) radiation delivered by radionuclides emitting α-particles or Auger electrons
|
Aghevlian, Sadaf
|
|
2017
|
136-137 |
C |
p. 102-118
17 p.
|
artikel
|
| 1655 |
Radiotherapy for Cancer: Present and Future
|
Allen, Christine
|
|
2017
|
136-137 |
C |
p. 1-2
2 p.
|
artikel
|
| 1656 |
Raman imaging of drug delivery systems
|
Smith, Geoffrey P.S.
|
|
2015
|
136-137 |
C |
p. 21-41
21 p.
|
artikel
|
| 1657 |
Raman microscopy for cellular investigations — From single cell imaging to drug carrier uptake visualization
|
Kann, Birthe
|
|
2015
|
136-137 |
C |
p. 71-90
20 p.
|
artikel
|
| 1658 |
Raman spectroscopy for medical diagnostics — From in-vitro biofluid assays to in-vivo cancer detection
|
Kong, Kenny
|
|
2015
|
136-137 |
C |
p. 121-134
14 p.
|
artikel
|
| 1659 |
Raman spectroscopy for physiological investigations of tissues and cells
|
Huser, Thomas
|
|
2015
|
136-137 |
C |
p. 57-70
14 p.
|
artikel
|
| 1660 |
Raman spectroscopy in pharmaceutical product design
|
Paudel, Amrit
|
|
2015
|
136-137 |
C |
p. 3-20
18 p.
|
artikel
|
| 1661 |
Rational designs of in vivo CRISPR-Cas delivery systems
|
Xu, Cong-Fei
|
|
|
136-137 |
C |
p. 3-29
|
artikel
|
| 1662 |
Rationally designed DNA-based nanocarriers
|
Jiang, Qiao
|
|
|
136-137 |
C |
p. 2-21
|
artikel
|
| 1663 |
Rationally designed drug delivery systems for the local treatment of resected glioblastoma
|
Bastiancich, Chiara
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1664 |
Recent advance in the pharmacogenomics of human Solute Carrier Transporters (SLCs) in drug disposition
|
Zhou, Fanfan
|
|
2017
|
136-137 |
C |
p. 21-36
16 p.
|
artikel
|
| 1665 |
Recent advancements in liposome technology
|
Filipczak, Nina
|
|
|
136-137 |
C |
p. 4-22
|
artikel
|
| 1666 |
Recent advances and future prospects: Current status and challenges of the intraocular injection of drugs for vitreoretinal diseases
|
Hashida, Noriyasu
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1667 |
Recent advances and prospects for lipid-based nanoparticles as drug carriers in the treatment of human retinal diseases
|
Zeng, Shaoxue
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1668 |
Recent advances and strategies for nanocarrier-mediated topical therapy and theranostic for posterior eye disease
|
Faria, Maria João
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1669 |
Recent advances in biomedical applications of 2D nanomaterials with peroxidase-like properties
|
Lyu, Zhaoyuan
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1670 |
Recent advances in cellular optogenetics for photomedicine
|
Chen, Bing
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1671 |
Recent advances in chemical modifications of guide RNA, mRNA and donor template for CRISPR-mediated genome editing
|
Chen, Qiubing
|
|
|
136-137 |
C |
p. 246-258
|
artikel
|
| 1672 |
Recent advances in co-amorphous drug formulations
|
Dengale, Swapnil Jayant
|
|
2016
|
136-137 |
C |
p. 116-125
10 p.
|
artikel
|
| 1673 |
Recent advances in degradable lactide-based shape-memory polymers
|
Balk, Maria
|
|
2016
|
136-137 |
C |
p. 136-152
|
artikel
|
| 1674 |
Recent advances in design of antimicrobial peptides and polypeptides toward clinical translation
|
Jiang, Yunjiang
|
|
|
136-137 |
C |
p. 261-280
|
artikel
|
| 1675 |
Recent advances in endocrine organoids for therapeutic application
|
Jeon, Suwan
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1676 |
Recent advances in lipid-based long-acting injectable depot formulations
|
Sharma, Reena
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1677 |
Recent advances in long-acting drug delivery systems for anticancer drug
|
Pacheco, Catarina
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1678 |
Recent advances in molecular, multimodal and theranostic ultrasound imaging
|
Kiessling, Fabian
|
|
2014
|
136-137 |
C |
p. 15-27
13 p.
|
artikel
|
| 1679 |
Recent advances in nanomaterials for therapy and diagnosis for atherosclerosis
|
Chen, Jun
|
|
|
136-137 |
C |
p. 142-199
|
artikel
|
| 1680 |
Recent advances in nanotherapeutic strategies for spinal cord injury repair
|
Song, Young Hye
|
|
|
136-137 |
C |
p. 38-59
|
artikel
|
| 1681 |
Recent advances in RNAi-based strategies for therapy and prevention of HIV-1/AIDS
|
Swamy, Manjunath N.
|
|
|
136-137 |
C |
p. 174-186
|
artikel
|
| 1682 |
Recent advances in self-assembled peptides: Implications for targeted drug delivery and vaccine engineering
|
Eskandari, Sharareh
|
|
2017
|
136-137 |
C |
p. 169-187
19 p.
|
artikel
|
| 1683 |
Recent advances in siRNA delivery mediated by lipid-based nanoparticles
|
Yonezawa, Sei
|
|
|
136-137 |
C |
p. 64-78
|
artikel
|
| 1684 |
Recent advances in the characterization of amorphous pharmaceuticals by X-ray diffractometry
|
Thakral, Seema
|
|
2016
|
136-137 |
C |
p. 183-193
11 p.
|
artikel
|
| 1685 |
Recent advances in the treatment of hyperammonemia
|
Matoori, Simon
|
|
2015
|
136-137 |
C |
p. 55-68
14 p.
|
artikel
|
| 1686 |
Recent advances of cocktail chemotherapy by combination drug delivery systems
|
Hu, Quanyin
|
|
2016
|
136-137 |
C |
p. 19-34
16 p.
|
artikel
|
| 1687 |
Recent advances of controlled drug delivery using microfluidic platforms
|
Sanjay, Sharma T.
|
|
2018
|
136-137 |
C |
p. 3-28
|
artikel
|
| 1688 |
Recent advances of focused ultrasound induced blood-brain barrier opening for clinical applications of neurodegenerative diseases
|
Zhao, Pengxuan
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1689 |
Recent advances of smart materials for ocular drug delivery
|
Wang, Xiaojun
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1690 |
Recent advances on anti-HIV vaginal delivery systems development
|
Antimisiaris, Sophia G.
|
|
2015
|
136-137 |
C |
p. 123-145
23 p.
|
artikel
|
| 1691 |
Recent applications of electrical, centrifugal, and pressurised emerging technologies for fibrous structure engineering in drug delivery, regenerative medicine and theranostics
|
Mehta, Prina
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1692 |
Recent applications of three-dimensional bioprinting in drug discovery and development
|
Yang, Kaixing
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1693 |
Recent coating developments for combination devices in orthopedic and dental applications: A literature review
|
Tobin, Eric J.
|
|
2017
|
136-137 |
C |
p. 88-100
13 p.
|
artikel
|
| 1694 |
Recent developments in lactose blend formulations for carrier-based dry powder inhalation
|
Hebbink, Gerald A.
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1695 |
Recent developments in micro- and nanofabrication techniques for the preparation of amorphous pharmaceutical dosage forms
|
Qi, Sheng
|
|
2016
|
136-137 |
C |
p. 67-84
18 p.
|
artikel
|
| 1696 |
Recent developments in the computational simulation of dry powder inhalers
|
Capecelatro, Jesse
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1697 |
Recent developments in the experimental investigations of relaxations in pharmaceuticals by dielectric techniques at ambient and elevated pressure
|
Grzybowska, Katarzyna
|
|
2016
|
136-137 |
C |
p. 158-182
25 p.
|
artikel
|
| 1698 |
Recent developments in the Raman and infrared investigations of amorphous pharmaceuticals and protein formulations: A review
|
Hédoux, Alain
|
|
2016
|
136-137 |
C |
p. 133-146
14 p.
|
artikel
|
| 1699 |
Recent insights in magnetic hyperthermia: From the “hot-spot” effect for local delivery to combined magneto-photo-thermia using magneto-plasmonic hybrids
|
Cazares-Cortes, Esther
|
|
2019
|
136-137 |
C |
p. 233-246
|
artikel
|
| 1700 |
Recent progresses in the exploration of machine learning methods as in-silico ADME prediction tools
|
Tao, L.
|
|
2015
|
136-137 |
C |
p. 83-100
18 p.
|
artikel
|
| 1701 |
Recent progress in development of siRNA delivery vehicles for cancer therapy
|
Kim, Hyun Jin
|
|
2016
|
136-137 |
C |
p. 61-77
17 p.
|
artikel
|
| 1702 |
Recent progress in microRNA delivery for cancer therapy by non-viral synthetic vectors
|
Wang, Huiyuan
|
|
2015
|
136-137 |
C |
p. 142-160
19 p.
|
artikel
|
| 1703 |
Recent progress in NIR-II fluorescence imaging-guided drug delivery for cancer theranostics
|
Roy, Shubham
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1704 |
Recent progress in upconversion nanomaterials for emerging optical biological applications
|
Chen, Hao
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1705 |
Recent progress of structural study of polymorphic pharmaceutical drugs
|
Higashi, Kenjirou
|
|
2017
|
136-137 |
C |
p. 71-85
15 p.
|
artikel
|
| 1706 |
Recent technological advancements in radiofrequency- andmicrowave-mediated hyperthermia for enhancing drug delivery
|
Paulides, M.M.
|
|
|
136-137 |
C |
p. 3-18
|
artikel
|
| 1707 |
Recent technological advancements in thermometry
|
Kokuryo, Daisuke
|
|
|
136-137 |
C |
p. 19-39
|
artikel
|
| 1708 |
Recent trends in drug-delivery systems for the treatment of diabetic retinopathy and associated fibrosis
|
Silva, Marta
|
|
|
136-137 |
C |
p. 439-460
|
artikel
|
| 1709 |
Recent trends in protein and peptide-based biomaterials for advanced drug delivery
|
Varanko, Anastasia
|
|
|
136-137 |
C |
p. 133-187
|
artikel
|
| 1710 |
Recombinant mucin biotechnology and engineering
|
Park, Sangwoo
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1711 |
Recombinant protein-based injectable materials for biomedical applications
|
Garcia Garcia, Cristobal
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1712 |
Recombinant protein polymer-antibody conjugates for applications in nanotechnology and biomedicine
|
Goncalves, Antonio G.
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1713 |
Recombinant protein polymers as carriers of chemotherapeutic agents
|
Phour, Anjali
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1714 |
Recombinant protein vaccines, a proven approach against coronavirus pandemics
|
Pollet, Jeroen
|
|
|
136-137 |
C |
p. 71-82
|
artikel
|
| 1715 |
Reconstructing the tumor architecture into organoids
|
Luo, Zhimin
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1716 |
Rectal route in the 21st Century to treat children
|
Jannin, Vincent
|
|
2014
|
136-137 |
C |
p. 34-49
16 p.
|
artikel
|
| 1717 |
Red blood cells: The metamorphosis of a neglected carrier into the natural mothership for artificial nanocarriers
|
Glassman, Patrick M.
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1718 |
Reduction-sensitive polymeric nanomedicines: An emerging multifunctional platform for targeted cancer therapy
|
Sun, Huanli
|
|
2018
|
136-137 |
C |
p. 16-32
|
artikel
|
| 1719 |
Re-epithelialization of adult skin wounds: Cellular mechanisms and therapeutic strategies
|
Rousselle, Patricia
|
|
2019
|
136-137 |
C |
p. 344-365
|
artikel
|
| 1720 |
Regenerative medicine for digestive fistulae therapy: Benefits, challenges and promises of stem/stromal cells and emergent perspectives via their extracellular vesicles
|
Sebbagh, Anna C.
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1721 |
Regenerative medicine for the treatment of reproductive system disorders: Current and potential options
|
Sadri-Ardekani, Hooman
|
|
2015
|
136-137 |
C |
p. 145-152
8 p.
|
artikel
|
| 1722 |
Regulation of in vivo delivery of nanomedicines by herbal medicines
|
Guan, Juan
|
|
|
136-137 |
C |
p. 210-228
|
artikel
|
| 1723 |
Regulatory aspects of small molecule drugs for heart regeneration
|
Rodgers, Kathleen
|
|
2016
|
136-137 |
C |
p. 245-252
8 p.
|
artikel
|
| 1724 |
Regulatory challenges for autologous tissue engineered products on their way from bench to bedside in Europe
|
Ram-Liebig, Gouya
|
|
2015
|
136-137 |
C |
p. 181-191
11 p.
|
artikel
|
| 1725 |
Regulatory challenges of nanomedicines and their follow-on versions: A generic or similar approach?
|
Mühlebach, Stefan
|
|
2018
|
136-137 |
C |
p. 122-131
|
artikel
|
| 1726 |
Regulatory guidelines and preclinical tools to study the biodistribution of RNA therapeutics
|
Vervaeke, P.
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1727 |
Regulatory pitfalls and opportunities when repurposing for inhalation therapy
|
Lyapustina, Svetlana
|
|
2018
|
136-137 |
C |
p. 57-65
|
artikel
|
| 1728 |
Remotely controlled opening of delivery vehicles and release of cargo by external triggers
|
Zhu, Dingcheng
|
|
2019
|
136-137 |
C |
p. 117-132
|
artikel
|
| 1729 |
Repairing the heart: State-of the art delivery strategies for biological therapeutics
|
Yang, Qiangbing
|
|
|
136-137 |
C |
p. 1-18
|
artikel
|
| 1730 |
Repetitive drug delivery using Light-Activated liposomes for potential antimicrobial therapies
|
Yuan, Zheng
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1731 |
Reply to the comment by Cipolla et al. on: Inhaled antimicrobial therapy—Barriers to effective treatment, by J. Weers, Adv. Drug Deliv. Rev. (2015), http://dx.doi.org/10.1016/j.addr.2014.08.013
|
Weers, Jeffry
|
|
2015
|
136-137 |
C |
p. e8-e10
nvt p.
|
artikel
|
| 1732 |
Reply to the comment by de Boer and Hoppentocht on: Inhaled Antimicrobial therapy – Barriers to effective treatment, by J. Weers, Adv. Drug Deliv. Rev. (2015), http://dx.doi.org/10.1016/j.addr.2014.08.013
|
Weers, Jeffry
|
|
2015
|
136-137 |
C |
p. e3-e5
nvt p.
|
artikel
|
| 1733 |
Reproducibility, relevance and reliability as barriers to efficient and credible biomedical technology translation
|
Dirnagl, Ulrich
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1734 |
Reprograming the immune niche for skin tissue regeneration – From cellular mechanisms to biomaterials applications
|
Mu, Ruoyu
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1735 |
Reprogramming lymphocytes for the treatment of melanoma: From biology to therapy
|
Margolis, Naama
|
|
2019
|
136-137 |
C |
p. 104-124
|
artikel
|
| 1736 |
(Re-)programming of subtype specific cardiomyocytes
|
Hausburg, Frauke
|
|
2017
|
136-137 |
C |
p. 142-167
|
artikel
|
| 1737 |
Reprogramming the lymphocyte axis for advanced immunotherapy
|
Moghimi, S. Moein
|
|
2019
|
136-137 |
C |
p. 1-2
|
artikel
|
| 1738 |
Repurposing drugs as inhaled therapies in asthma
|
Anderson, Sandra D.
|
|
2018
|
136-137 |
C |
p. 19-33
|
artikel
|
| 1739 |
Repurposing excipients as active inhalation agents: The mannitol story
|
Anderson, Sandra D.
|
|
2018
|
136-137 |
C |
p. 45-56
|
artikel
|
| 1740 |
Repurposing of gamma interferon via inhalation delivery
|
Smaldone, Gerald C.
|
|
2018
|
136-137 |
C |
p. 87-92
|
artikel
|
| 1741 |
Repurposing of statins via inhalation to treat lung inflammatory conditions
|
Bradbury, Peta
|
|
2018
|
136-137 |
C |
p. 93-106
|
artikel
|
| 1742 |
Rescue plan for Achilles: Therapeutics steering the fate and functions of stem cells in tendon wound healing
|
Schneider, Magdalena
|
|
|
136-137 |
C |
p. 352-375
|
artikel
|
| 1743 |
Research trends in biomedical applications of two-dimensional nanomaterials over the last decade – A bibliometric analysis
|
Zhu, Shuang
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1744 |
Responsive Nanocarriers as an Emerging Platform for Cascaded Delivery of Nucleic Acids to Cancer
|
Liu, Yang
|
|
2017
|
136-137 |
C |
p. 98-114
17 p.
|
artikel
|
| 1745 |
Responsive nanomedicines enhanced by or enhancing physical modalities to treat solid cancer tumors: Preclinical and clinical evidence of safety and efficacy
|
Papaioannou, Ligeri
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1746 |
Responsive optical probes for deep-tissue imaging: Photoacoustics and second near-infrared fluorescence
|
Ding, Fei
|
|
|
136-137 |
C |
p. 141-163
|
artikel
|
| 1747 |
Responsive triggering systems for delivery in chronic wound healing
|
Morey, Mangesh
|
|
|
136-137 |
C |
p. 169-193
|
artikel
|
| 1748 |
Restoration of skin pigmentation after deep partial or full-thickness burn injury
|
Dai, Niann-Tzyy
|
|
2018
|
136-137 |
C |
p. 155-164
|
artikel
|
| 1749 |
Revealing the clinical potential of high-resolution organoids
|
Ko, Jihoon
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1750 |
Reversibility and therapeutic development for neurodevelopmental disorders, insights from genetic animal models
|
Megagiannis, Platon
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1751 |
Review: Antimicrobial efficacy validation using in vitro and in vivo testing methods
|
Omar, Amin
|
|
2017
|
136-137 |
C |
p. 61-68
8 p.
|
artikel
|
| 1752 |
Review of paediatric gastrointestinal physiology relevant to the absorption of orally administered medicines
|
Wollmer, Erik
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1753 |
Reviving the interest in the versatile drug nystatin: A multitude of strategies to increase its potential as an effective and safe antifungal agent
|
Sousa, Filipa
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1754 |
Risk assessment of neonatal excipient exposure: Lessons from food safety and other areas
|
Turner, M.A.
|
|
2014
|
136-137 |
C |
p. 89-101
13 p.
|
artikel
|
| 1755 |
RNA binding proteins (RBPs) and their role in DNA damage and radiation response in cancer
|
Mehta, Meghna
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1756 |
RNA delivery technologies: From concept toward the clinic
|
Blanco-Prieto, María J.
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1757 |
RNAi-based therapeutics and tumor targeted delivery in cancer
|
Kara, Goknur
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1758 |
RNA imaging by chemical probes
|
Tomoike, Fumiaki
|
|
|
136-137 |
C |
p. 44-58
|
artikel
|
| 1759 |
RNAi therapies: Expanding applications for extrahepatic diseases and overcoming delivery challenges
|
Won Lee, Jong
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1760 |
RNA-loaded nanoparticles for the treatment of hematological cancers
|
Garbayo, Elisa
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1761 |
RNA therapies for CNS diseases
|
Di Francesco, Valentina
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1762 |
Robust and smart polypeptide-based nanomedicines for targeted tumor therapy
|
Deng, Chao
|
|
|
136-137 |
C |
p. 199-211
|
artikel
|
| 1763 |
Role and modulation of drug transporters in HIV-1 therapy
|
Alam, Camille
|
|
|
136-137 |
C |
p. 121-143
|
artikel
|
| 1764 |
Role of CFD based in silico modelling in establishing an in vitro-in vivo correlation of aerosol deposition in the respiratory tract
|
Huang, Fen
|
|
|
136-137 |
C |
p. 369-385
|
artikel
|
| 1765 |
Role of extracellular vesicles in liver diseases and their therapeutic potential
|
Kostallari, Enis
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1766 |
Role of microbiome, microenvironment and novel drug delivery system in the wound healing
|
Luo, Gaoxing
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1767 |
Role of microRNAs in maintaining cancer stem cells
|
Garofalo, Michela
|
|
2015
|
136-137 |
C |
p. 53-61
9 p.
|
artikel
|
| 1768 |
Role of nanotechnology in HIV/AIDS vaccine development
|
Liu, Ying
|
|
|
136-137 |
C |
p. 76-89
|
artikel
|
| 1769 |
Role of pharmacokinetic consideration for the development of drug delivery systems: A historical overview
|
Hashida, Mitsuru
|
|
|
136-137 |
C |
p. 71-82
|
artikel
|
| 1770 |
Role of wound microbiome, strategies of microbiota delivery system and clinical management
|
Tang, Qinghan
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1771 |
Roles of interfacial water states on advanced biomedical material design
|
Nishida, Kei
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1772 |
Rule of five in 2015 and beyond: Target and ligand structural limitations, ligand chemistry structure and drug discovery project decisions
|
Lipinski, Christopher A.
|
|
2016
|
136-137 |
C |
p. 34-41
8 p.
|
artikel
|
| 1773 |
SARS-CoV-2 vaccines in advanced clinical trials: Where do we stand?
|
Chakraborty, Saborni
|
|
|
136-137 |
C |
p. 314-338
|
artikel
|
| 1774 |
Scaffold biomaterials for nano-pathophysiology
|
Yamamoto, Masaya
|
|
2014
|
136-137 |
C |
p. 104-114
11 p.
|
artikel
|
| 1775 |
Scaffold-mediated sequential drug/gene delivery to promote nerve regeneration and remyelination following traumatic nerve injuries
|
Ong, William
|
|
|
136-137 |
C |
p. 19-48
|
artikel
|
| 1776 |
Scaffolds, cells, biologics: At the crossroads of musculoskeletal repair
|
Zeugolis, Dimitrios I.
|
|
2015
|
136-137 |
C |
p. v-vi
nvt p.
|
artikel
|
| 1777 |
Scaled preparation of extracellular vesicles from conditioned media
|
Staubach, Simon
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1778 |
Scarless wound healing: From development to senescence
|
Pratsinis, Harris
|
|
2019
|
136-137 |
C |
p. 325-343
|
artikel
|
| 1779 |
Scar management in burn injuries using drug delivery and molecular signaling: Current treatments and future directions
|
Amini-Nik, Saeid
|
|
2018
|
136-137 |
C |
p. 135-154
|
artikel
|
| 1780 |
Scarring vs. functional healing: Matrix-based strategies to regulate tissue repair
|
Keane, Timothy J.
|
|
|
136-137 |
C |
p. 407-419
|
artikel
|
| 1781 |
Scientific and regulatory activities initiated by the U.S. Food and drug administration to foster approvals of generic dry powder inhalers: Bioequivalence perspective
|
Newman, Bryan
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1782 |
Scientific and regulatory activities initiated by the U.S. food and drug administration to foster approvals of generic dry powder inhalers: Quality perspective
|
El-Gendy, Nashwa
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1783 |
Screening for new pharmaceutical solid forms using mechanochemistry: A practical guide
|
Hasa, Dritan
|
|
2017
|
136-137 |
C |
p. 147-161
15 p.
|
artikel
|
| 1784 |
Second near-infrared window fluorescence nanoprobes for deep-tissue in vivo multiplexed bioimaging
|
Yang, Yanling
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1785 |
SEDDS: A game changing approach for the oral administration of hydrophilic macromolecular drugs
|
Mahmood, Arshad
|
|
2019
|
136-137 |
C |
p. 91-101
|
artikel
|
| 1786 |
Seeing through the skin: Optical methods for visualizing transdermal drug delivery with microneedles
|
Limcharoen, Benchaphorn
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1787 |
Selective delivery of imaging probes and therapeutics to the endoplasmic reticulum or Golgi apparatus: Current strategies and beyond
|
Cho, Hana
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1788 |
Self-assembled mRNA vaccines
|
Kim, Jeonghwan
|
|
|
136-137 |
C |
p. 83-112
|
artikel
|
| 1789 |
Self-assembling nanocarriers from engineered proteins: Design, functionalization, and application for drug delivery
|
Li, Yirui
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1790 |
Self-assembling peptide-based building blocks in medical applications
|
Acar, Handan
|
|
2017
|
136-137 |
C |
p. 65-79
15 p.
|
artikel
|
| 1791 |
Self-assembling peptide-based delivery of therapeutics for myocardial infarction
|
French, Kristin M.
|
|
2016
|
136-137 |
C |
p. 40-53
14 p.
|
artikel
|
| 1792 |
Self-assembling peptides as vectors for local drug delivery and tissue engineering applications
|
Karavasili, Christina
|
|
|
136-137 |
C |
p. 387-405
|
artikel
|
| 1793 |
Self-assembly and bioconjugation in drug delivery
|
Gormley, Adam J.
|
|
|
136-137 |
C |
p. 628-629
|
artikel
|
| 1794 |
Self-assembly of protein-polymer conjugates for drug delivery
|
Stevens, Corey. A.
|
|
|
136-137 |
C |
p. 447-460
|
artikel
|
| 1795 |
Self-emulsifying drug delivery system: Mucus permeation and innovative quantification technologies
|
Abdulkarim, Muthanna
|
|
2019
|
136-137 |
C |
p. 62-74
|
artikel
|
| 1796 |
Self-emulsifying drug delivery systems (SEDDS) – The splendid comeback of an old technology
|
Bernkop-Schnürch, Andreas
|
|
2019
|
136-137 |
C |
p. 1-2
|
artikel
|
| 1797 |
Sensing technologies and experimental platforms for the characterization of advanced oral drug delivery systems
|
Okeyo, Peter Ouma
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1798 |
Separation, characterization, and standardization of extracellular vesicles for drug delivery applications
|
Buschmann, Dominik
|
|
|
136-137 |
C |
p. 348-368
|
artikel
|
| 1799 |
Sequential drug delivery for liver diseases
|
Huang, Xiaozhong
|
|
|
136-137 |
C |
p. 72-84
|
artikel
|
| 1800 |
Sequential drug delivery to modulate macrophage behavior and enhance implant integration
|
O'Brien, Erin M.
|
|
|
136-137 |
C |
p. 85-94
|
artikel
|
| 1801 |
Sequential drug/gene delivery in tissue engineering & regenerative medicine
|
Chew, Sing Yian
|
|
|
136-137 |
C |
p. 1
|
artikel
|
| 1802 |
Shape memory materials and 4D printing in pharmaceutics
|
Melocchi, Alice
|
|
|
136-137 |
C |
p. 216-237
|
artikel
|
| 1803 |
Sharpening nature's tools for efficient tuberculosis control: A review of the potential role and development of host-directed therapies and strategies for targeted respiratory delivery
|
O'Connor, Gemma
|
|
2016
|
136-137 |
C |
p. 33-54
22 p.
|
artikel
|
| 1804 |
Shedding light on ultrasound in action: Optical and optoacoustic monitoring of ultrasound brain interventions
|
Eleni Karakatsani, Maria
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1805 |
Silica nanoparticles: A review of their safety and current strategies to overcome biological barriers
|
Janjua, Taskeen Iqbal
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1806 |
Silicon oxide based materials for controlled release in orthopedic procedures
|
Qu, Haibo
|
|
2015
|
136-137 |
C |
p. 96-115
20 p.
|
artikel
|
| 1807 |
Silk-elastinlike protein-based hydrogels for drug delivery and embolization
|
Griswold, Ethan
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1808 |
Silk fibroin for skin injury repair: Where do things stand?
|
Gholipourmalekabadi, Mazaher
|
|
|
136-137 |
C |
p. 28-53
|
artikel
|
| 1809 |
Single molecule microscopy in 3D cell cultures and tissues
|
Lauer, Florian M.
|
|
2014
|
136-137 |
C |
p. 79-94
16 p.
|
artikel
|
| 1810 |
siRNA Delivery to the lung: What's new?
|
Merkel, Olivia M.
|
|
2014
|
136-137 |
C |
p. 112-128
17 p.
|
artikel
|
| 1811 |
siRNA drug delivery across the blood–brain barrier in Alzheimer's disease
|
Imran Sajid, Muhammad
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1812 |
Size-based separation methods of circulating tumor cells
|
Hao, Si-Jie
|
|
|
136-137 |
C |
p. 3-20
|
artikel
|
| 1813 |
Size-dependent penetration depth of colloidal nanoparticles into cell spheroids
|
Zhu, Dingcheng
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1814 |
Slings for urinary incontinence and the application of cell-based therapy
|
Hakim, Lukman
|
|
2015
|
136-137 |
C |
p. 22-30
9 p.
|
artikel
|
| 1815 |
Small molecule compounds targeting miRNAs for cancer therapy
|
Monroig, Paloma del C.
|
|
2015
|
136-137 |
C |
p. 104-116
13 p.
|
artikel
|
| 1816 |
Smart biomaterials to enhance the efficiency of immunotherapy in glioblastoma: State of the art and future perspectives
|
Abadi, Banafshe
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1817 |
Smart contact lens systems for ocular drug delivery and therapy
|
Kim, Tae Yeon
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1818 |
Smart drug delivery platforms reprogramming cancer immune cycle to mitigate immune resistance of pancreatic tumors
|
Zhang, Ping
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1819 |
Smart dry powder inhalers and intelligent adherence management
|
Häußermann, Sabine
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1820 |
Smart gating porous particles as new carriers for drug delivery
|
Thananukul, Kamonchanok
|
|
|
136-137 |
C |
p. 425-446
|
artikel
|
| 1821 |
Smart pills for gastrointestinal diagnostics and therapy
|
Cummins, G.
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1822 |
Soft nano and microstructures for the photomodulation of cellular signaling and behavior
|
Muzzio, Nicolas
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1823 |
Solidification to improve the biopharmaceutical performance of SEDDS: Opportunities and challenges
|
Joyce, Paul
|
|
2019
|
136-137 |
C |
p. 102-117
|
artikel
|
| 1824 |
Solid implantable devices for sustained drug delivery
|
Magill, Elizabeth
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1825 |
Solid state of inhalable high dose powders
|
Adhikari, Bishal Raj
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1826 |
Spatial regulation of controlled bioactive factor delivery for bone tissue engineering
|
Samorezov, Julia E.
|
|
2015
|
136-137 |
C |
p. 45-67
23 p.
|
artikel
|
| 1827 |
Spatiotemporal delivery of bioactive molecules for wound healing using stimuli-responsive biomaterials
|
Oliva, Nuria
|
|
|
136-137 |
C |
p. 22-41
|
artikel
|
| 1828 |
Special issue: Extracellular matrix: Therapeutic tools and targets in cancer treatment
|
Schaefer, Liliana
|
|
2016
|
136-137 |
C |
p. 1-3
3 p.
|
artikel
|
| 1829 |
Special issue on vaginal drug delivery
|
de Oliveira, Rita Palmeira
|
|
2015
|
136-137 |
C |
p. 1-
1 p.
|
artikel
|
| 1830 |
Special issue: Polylactide (PLA) Based Biopolymers
|
Langer, Robert
|
|
2016
|
136-137 |
C |
p. 1-2
|
artikel
|
| 1831 |
Special Issue (SI) on: Emerging pharmaceutical technologies (From advanced materials & formulations to new processes) for novel dosage development
|
Ahmad, Zeeshan
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1832 |
Specialized pro-resolving lipid mediators in cardiovascular disease, diagnosis, and therapy
|
Kim, Alexander S.
|
|
|
136-137 |
C |
p. 170-179
|
artikel
|
| 1833 |
Specific mechanical energy – An essential parameter in the processing of amorphous solid dispersions
|
Thompson, Stephen A.
|
|
|
136-137 |
C |
p. 374-393
|
artikel
|
| 1834 |
Spectral computed tomography with inorganic nanomaterials: State-of-the-art
|
Li, Yuhan
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1835 |
Spectroscopic techniques for monitoring stem cell and organoid proliferation in 3D environments for therapeutic development
|
Mao, Wei
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1836 |
Sphingolipids as prognostic biomarkers of neurodegeneration, neuroinflammation, and psychiatric diseases and their emerging role in lipidomic investigation methods
|
van Kruining, Daan
|
|
|
136-137 |
C |
p. 232-244
|
artikel
|
| 1837 |
Sphingolipids as targets for inhalation treatment of cystic fibrosis
|
Becker, Katrin Anne
|
|
2018
|
136-137 |
C |
p. 66-75
|
artikel
|
| 1838 |
Sphingolipids in Alzheimer's disease, how can we target them?
|
Crivelli, Simone M.
|
|
|
136-137 |
C |
p. 214-231
|
artikel
|
| 1839 |
Spray drying formulation of amorphous solid dispersions
|
Singh, Abhishek
|
|
2016
|
136-137 |
C |
p. 27-50
24 p.
|
artikel
|
| 1840 |
Stability of lyophilized and spray dried vaccine formulations
|
Preston, Kendall B.
|
|
|
136-137 |
C |
p. 50-61
|
artikel
|
| 1841 |
Stabilization Challenges and Formulation Strategies Associated with Oral Biologic Drug Delivery Systems
|
Truong-Le, Vu
|
|
2015
|
136-137 |
C |
p. 95-108
14 p.
|
artikel
|
| 1842 |
Stabilization of proteins in solid form
|
Cicerone, Marcus T.
|
|
2015
|
136-137 |
C |
p. 14-24
11 p.
|
artikel
|
| 1843 |
Stabilizers and their interaction with formulation components in frozen and freeze-dried protein formulations
|
Thakral, Seema
|
|
|
136-137 |
C |
p. 1-19
|
artikel
|
| 1844 |
Stabilizing vaccines via drying: Quality by design considerations
|
Ghaemmaghamian, Zahra
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1845 |
Stable RNA nanoparticles as potential new generation drugs for cancer therapy
|
Shu, Yi
|
|
2014
|
136-137 |
C |
p. 74-89
16 p.
|
artikel
|
| 1846 |
State-of-the-art materials for ultrasound-triggered drug delivery
|
Sirsi, Shashank R.
|
|
2014
|
136-137 |
C |
p. 3-14
12 p.
|
artikel
|
| 1847 |
Stealth and pseudo-stealth nanocarriers
|
Wen, Panyue
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1848 |
Stem cell based human organ-on-a-chip models for drug discovery and development
|
Loskill, Peter
|
|
2019
|
136-137 |
C |
p. 1-2
|
artikel
|
| 1849 |
Stem cell-based Lung-on-Chips: The best of both worlds?
|
Nawroth, Janna C.
|
|
2019
|
136-137 |
C |
p. 12-32
|
artikel
|
| 1850 |
Stem-cell based organ-on-a-chip models for diabetes research
|
Rogal, Julia
|
|
2019
|
136-137 |
C |
p. 101-128
|
artikel
|
| 1851 |
Stem cell-based peripheral vascular regeneration
|
Fujita, Yasuyuki
|
|
2017
|
136-137 |
C |
p. 25-40
|
artikel
|
| 1852 |
Stem cell-based retina models
|
Achberger, Kevin
|
|
2019
|
136-137 |
C |
p. 33-50
|
artikel
|
| 1853 |
Stem cell-based therapies for HIV/AIDS
|
Pernet, Olivier
|
|
|
136-137 |
C |
p. 187-201
|
artikel
|
| 1854 |
Stem cells and heart disease - Brake or accelerator?
|
Steinhoff, Gustav
|
|
2017
|
136-137 |
C |
p. 2-24
|
artikel
|
| 1855 |
Stem cells as drug delivery methods: Application of stem cell secretome for regeneration
|
Tran, Christine
|
|
2015
|
136-137 |
C |
p. 1-11
11 p.
|
artikel
|
| 1856 |
Stem cells, niches and scaffolds: Applications to burns and wound care
|
Watt, Suzanne M.
|
|
2018
|
136-137 |
C |
p. 82-106
|
artikel
|
| 1857 |
Stem cell therapy clinical research: A regulatory conundrum for academia
|
Nagpal, Anjali
|
|
2017
|
136-137 |
C |
p. 105-114
|
artikel
|
| 1858 |
Stem cell treatment of erectile dysfunction
|
Alwaal, Amjad
|
|
2015
|
136-137 |
C |
p. 137-144
8 p.
|
artikel
|
| 1859 |
Stereotactic ablative body radiosurgery (SABR) or Stereotactic body radiation therapy (SBRT)
|
Folkert, Michael R.
|
|
2017
|
136-137 |
C |
p. 3-14
12 p.
|
artikel
|
| 1860 |
Steric stabilization of bioactive nanoparticles using elastin-like polypeptides
|
Phan, Alvin
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1861 |
Stimuli-responsive cross-linked micelles for on-demand drug delivery against cancers
|
Li, Yuanpei
|
|
2014
|
136-137 |
C |
p. 58-73
16 p.
|
artikel
|
| 1862 |
Stimuli-responsive drug delivery systems triggered by intracellular or subcellular microenvironments
|
Sun, Tao
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1863 |
Storming the gate: New approaches for targeting the dynamic tight junction for improved drug delivery
|
Ramirez-Velez, Isabela
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1864 |
Strategic design of extracellular vesicle drug delivery systems
|
Armstrong, James P.K.
|
|
2018
|
136-137 |
C |
p. 12-16
|
artikel
|
| 1865 |
Strategies and progresses for enhancing targeted antibiotic delivery
|
Nazli, Adila
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1866 |
Strategies, design, and chemistry in siRNA delivery systems
|
Dong, Yizhou
|
|
|
136-137 |
C |
p. 133-147
|
artikel
|
| 1867 |
Strategies employed in the design and optimization of synthetic antimicrobial peptide amphiphiles with enhanced therapeutic potentials
|
Ong, Zhan Yuin
|
|
2014
|
136-137 |
C |
p. 28-45
18 p.
|
artikel
|
| 1868 |
Strategies for controlled delivery of biologics for cartilage repair
|
Lam, Johnny
|
|
2015
|
136-137 |
C |
p. 123-134
12 p.
|
artikel
|
| 1869 |
Strategies for controlling the innate immune activity of conventional and self-amplifying mRNA therapeutics: Getting the message across
|
Minnaert, An-Katrien
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1870 |
Strategies for developing complex multi-component in vitro tumor models: Highlights in glioblastoma
|
DePalma, Thomas J.
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1871 |
Strategies for improving diabetic therapy via alternative administration routes that involve stimuli-responsive insulin-delivering systems
|
Lin, Yu-Jung
|
|
2019
|
136-137 |
C |
p. 71-82
|
artikel
|
| 1872 |
Strategies for overcoming protein and peptide instability in biodegradable drug delivery systems
|
Shi, Miusi
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1873 |
Strategies targeting tumor immune and stromal microenvironment and their clinical relevance
|
Hu, Mengying
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1874 |
Strategies to develop endogenous stem cell-recruiting bioactive materials for tissue repair and regeneration
|
Pacelli, Settimio
|
|
2017
|
136-137 |
C |
p. 50-70
|
artikel
|
| 1875 |
Strategies to develop polymeric microneedles for controlled drug release
|
Chen, Bo Zhi
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1876 |
Strategies to engineer tendon/ligament-to-bone interface: Biomaterials, cells and growth factors
|
Font Tellado, Sonia
|
|
2015
|
136-137 |
C |
p. 126-140
15 p.
|
artikel
|
| 1877 |
Strategies to enhance drug delivery to solid tumors by harnessing the EPR effects and alternative targeting mechanisms
|
Zi, Yixuan
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1878 |
Strategies to overcome/penetrate the BBB for systemic nanoparticle delivery to the brain/brain tumor
|
Liu, Hai-Jun
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1879 |
Strategies to overcome the polycation dilemma in drug delivery
|
Bernkop-Schnürch, Andreas
|
|
2018
|
136-137 |
C |
p. 62-72
|
artikel
|
| 1880 |
Strengths, weaknesses, opportunities and challenges for long acting injectable therapies: Insights for applications in HIV therapy
|
Owen, Andrew
|
|
|
136-137 |
C |
p. 144-156
|
artikel
|
| 1881 |
Stress urinary incontinence animal models as a tool to study cell-based regenerative therapies targeting the urethral sphincter
|
Herrera-Imbroda, Bernardo
|
|
2015
|
136-137 |
C |
p. 106-116
11 p.
|
artikel
|
| 1882 |
Stromal regulation of tumor-associated lymphatics
|
Munir, Hafsa
|
|
|
136-137 |
C |
p. 75-89
|
artikel
|
| 1883 |
Structural and functional stabilization of protein entities: state-of-the-art
|
Balcão, Victor M.
|
|
2015
|
136-137 |
C |
p. 25-41
17 p.
|
artikel
|
| 1884 |
Structural and thermodynamic aspects of plasticization and antiplasticization in glassy encapsulation and biostabilization matrices
|
Ubbink, Job
|
|
2016
|
136-137 |
C |
p. 10-26
17 p.
|
artikel
|
| 1885 |
Studies and methodologies on vaginal drug permeation
|
Machado, Rita Monteiro
|
|
2015
|
136-137 |
C |
p. 14-26
13 p.
|
artikel
|
| 1886 |
Studying the influence of angiogenesis in in vitro cancer model systems
|
Roudsari, Laila C.
|
|
2016
|
136-137 |
C |
p. 250-259
10 p.
|
artikel
|
| 1887 |
Subcellular targeting strategies for protein and peptide delivery
|
Su, Hao
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1888 |
Subcellular visualization: Organelle-specific targeted drug delivery and discovery
|
Shao, Xintian
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1889 |
Subchronic and chronic toxicity evaluation of inorganic nanoparticles for delivery applications
|
Mohammadpour, Raziye
|
|
|
136-137 |
C |
p. 112-132
|
artikel
|
| 1890 |
Substrate mediated enzyme prodrug therapy
|
Fejerskov, Betina
|
|
2017
|
136-137 |
C |
p. 24-34
|
artikel
|
| 1891 |
Successful development of oral SEDDS: screening of excipients from the industrial point of view
|
Nardin, Isabelle
|
|
2019
|
136-137 |
C |
p. 128-140
|
artikel
|
| 1892 |
Sung Wan Kim (1940–2020) Pioneer of Drug and Gene Delivery
|
Kopeček, Jindřich Henry
|
|
|
136-137 |
C |
p. 3
|
artikel
|
| 1893 |
Supercritical carbon dioxide-based technologies for the production of drug nanoparticles/nanocrystals – A comprehensive review
|
Padrela, Luís
|
|
2018
|
136-137 |
C |
p. 22-78
|
artikel
|
| 1894 |
Supercritical fluid (SCF)-assisted fabrication of carrier-free drugs: An eco-friendly welcome to active pharmaceutical ingredients (APIs)
|
Kankala, Ranjith Kumar
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1895 |
Superparamagnetic iron oxides as MPI tracers: A primer and review of early applications
|
Bulte, Jeff W.M.
|
|
2019
|
136-137 |
C |
p. 293-301
|
artikel
|
| 1896 |
Super-resolution fluorescence microscopic imaging in pathogenesis and drug treatment of neurological disease
|
Gong, Jihong
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1897 |
Super-resolution mid-infrared spectro-microscopy of biological applications through tapping mode and peak force tapping mode atomic force microscope
|
Wang, Haomin
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1898 |
Supramolecular engineering of hydrogels for drug delivery
|
Bernhard, Stéphane
|
|
|
136-137 |
C |
p. 240-256
|
artikel
|
| 1899 |
Surface engineering for lymphocyte programming
|
Ben-Akiva, Elana
|
|
2017
|
136-137 |
C |
p. 102-115
|
artikel
|
| 1900 |
Surface mobility of molecular glasses and its importance in physical stability
|
Yu, Lian
|
|
2016
|
136-137 |
C |
p. 3-9
7 p.
|
artikel
|
| 1901 |
Surface modification of two-dimensional layered double hydroxide nanoparticles with biopolymers for biomedical applications
|
Pavlovic, Marko
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1902 |
Sustained delivery approaches to improving adaptive immune responses
|
Ou, Ben S.
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1903 |
Synergies between therapeutic ultrasound, gene therapy and immunotherapy in cancer treatment
|
Zhang, Nisi
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1904 |
Synergistic nanomedicine by combined gene and photothermal therapy
|
Kim, Jinhwan
|
|
2016
|
136-137 |
C |
p. 99-112
14 p.
|
artikel
|
| 1905 |
Synergistic use of biomaterials and licensed therapeutics to manipulate bone remodelling and promote non-union fracture repair
|
Simpson, Christopher R.
|
|
|
136-137 |
C |
p. 212-233
|
artikel
|
| 1906 |
Synthesis and biomedical applications of mucin mimic materials
|
Kohout, Victoria R.
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1907 |
Synthetic biology-guided design and biosynthesis of protein polymers for delivery
|
Tian, Kai-Kai
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1908 |
Synthetic chemical ligands and cognate antibodies for biorthogonal drug targeting and cell engineering
|
Monge, Pere
|
|
|
136-137 |
C |
p. 281-293
|
artikel
|
| 1909 |
Synthetic multi-layer nanoparticles for CRISPR-Cas9 genome editing
|
Tang, Hao
|
|
|
136-137 |
C |
p. 55-78
|
artikel
|
| 1910 |
Synthetic peptide hydrogels as 3D scaffolds for tissue engineering
|
Ding, Xin
|
|
|
136-137 |
C |
p. 78-104
|
artikel
|
| 1911 |
Synthetic polypeptides for drug and gene delivery, and tissue engineering
|
Yin, Lichen
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1912 |
Synthetic RNA-based post-transcriptional expression control methods and genetic circuits
|
Pardi, Malvin L.
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1913 |
Synthetic T cell receptor-based lymphocytes for cancer therapy
|
Getts, Daniel
|
|
2019
|
136-137 |
C |
p. 47-54
|
artikel
|
| 1914 |
Systemic delivery of peptides by the oral route: Formulation and medicinal chemistry approaches
|
Brayden, D.J.
|
|
|
136-137 |
C |
p. 2-36
|
artikel
|
| 1915 |
Tackling muscle fibrosis: From molecular mechanisms to next generation engineered models to predict drug delivery
|
Bersini, S.
|
|
|
136-137 |
C |
p. 64-77
|
artikel
|
| 1916 |
Tackling myelin deficits in neurodevelopmental disorders using drug delivery systems
|
Rokach, May
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1917 |
Tackling TNF-α in autoinflammatory disorders and autoimmune diseases: From conventional to cutting edge in biologics and RNA- based nanomedicines
|
Andretto, Valentina
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1918 |
Tailoring the physicochemical properties of nanomaterials for immunomodulation
|
Deng, Junjie
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1919 |
Target- and prodrug-based design for fungal diseases and cancer-associated fungal infections
|
Liu, Na
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1920 |
Targeted delivery as key for the success of small osteoinductive molecules
|
Balmayor, Elizabeth R.
|
|
2015
|
136-137 |
C |
p. 13-27
15 p.
|
artikel
|
| 1921 |
Targeted delivery methods for RNA interference are necessary to obtain a potential functional cure for HIV/AIDS
|
Cisneros, Ethan
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1922 |
Targeted drug delivery for maternal and perinatal health: Challenges and opportunities
|
Sharma, Anjali
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1923 |
Targeted drug delivery to melanoma
|
Liu, Qi
|
|
|
136-137 |
C |
p. 208-221
|
artikel
|
| 1924 |
Targeted electro-delivery of oligonucleotides for RNA interference: siRNA and antimiR
|
Chabot, Sophie
|
|
2015
|
136-137 |
C |
p. 161-168
8 p.
|
artikel
|
| 1925 |
Targeted imaging
|
Vandamme, Thierry F.
|
|
2014
|
136-137 |
C |
p. 1-
1 p.
|
artikel
|
| 1926 |
Targeted lipid nanoparticles for RNA therapeutics and immunomodulation in leukocytes
|
Veiga, Nuphar
|
|
|
136-137 |
C |
p. 364-376
|
artikel
|
| 1927 |
Targeted multimodal imaging modalities
|
Lee, Seung Yong
|
|
2014
|
136-137 |
C |
p. 60-78
19 p.
|
artikel
|
| 1928 |
Targeted nanotechnology for cancer imaging
|
Toy, Randall
|
|
2014
|
136-137 |
C |
p. 79-97
19 p.
|
artikel
|
| 1929 |
Targeted pulmonary delivery of inducers of host macrophage autophagy as a potential host-directed chemotherapy of tuberculosis
|
Gupta, Anuradha
|
|
2016
|
136-137 |
C |
p. 10-20
11 p.
|
artikel
|
| 1930 |
Targeted to neuronal organelles for CNS drug development
|
Ying, Zheng
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1931 |
Targeting and isolation of cancer cells using micro/nanomotors
|
Gao, Weiwei
|
|
|
136-137 |
C |
p. 94-101
|
artikel
|
| 1932 |
Targeting and therapeutic peptide-based strategies for polycystic kidney disease
|
Wang, Jonathan
|
|
|
136-137 |
C |
p. 176-189
|
artikel
|
| 1933 |
Targeting bacterial metabolites in tumor for cancer therapy: An alternative approach for targeting tumor-associated bacteria
|
Ji, Guofeng
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1934 |
Targeting cancer epigenetics: Linking basic biology to clinical medicine
|
Shinjo, Keiko
|
|
2015
|
136-137 |
C |
p. 56-64
9 p.
|
artikel
|
| 1935 |
Targeting cell plasticity for regeneration: From in vitro to in vivo reprogramming
|
Romanazzo, Sara
|
|
|
136-137 |
C |
p. 124-144
|
artikel
|
| 1936 |
Targeting drug delivery in the vascular system: Focus on endothelium
|
Glassman, Patrick M.
|
|
|
136-137 |
C |
p. 96-117
|
artikel
|
| 1937 |
Targeting drug delivery with light: A highly focused approach
|
Rapp, Teresa L.
|
|
|
136-137 |
C |
p. 94-107
|
artikel
|
| 1938 |
Targeting fibrosis in the failing heart with nanoparticles
|
Passaro, Fabiana
|
|
|
136-137 |
C |
p. 461-481
|
artikel
|
| 1939 |
Targeting gut microbiota to alleviate neuroinflammation in Alzheimer’s disease
|
Thu Thuy Nguyen, Vu
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1940 |
Targeting microbiome, drug metabolism, and drug delivery in oncology
|
Sumiyoshi, Ai
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1941 |
Targeting myeloid cells using nanoparticles to improve cancer immunotherapy
|
Amoozgar, Zohreh
|
|
2015
|
136-137 |
C |
p. 38-51
14 p.
|
artikel
|
| 1942 |
Targeting renal fibrosis: Mechanisms and drug delivery systems
|
Nastase, Madalina V.
|
|
|
136-137 |
C |
p. 295-307
|
artikel
|
| 1943 |
Targeting the blood-brain barrier for the delivery of stroke therapies
|
D'Souza, Anisha
|
|
|
136-137 |
C |
p. 332-351
|
artikel
|
| 1944 |
Targeting the CD40-CD40L pathway in autoimmune diseases: Humoral immunity and beyond
|
Karnell, Jodi L.
|
|
2019
|
136-137 |
C |
p. 92-103
|
artikel
|
| 1945 |
Targeting the liver in dementia and cognitive impairment: Dietary macronutrients and diabetic therapeutics
|
Hunt, Nicholas J.
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1946 |
Targeting the physical microenvironment of tumors for drug and immunotherapy
|
Xu, Feng
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1947 |
Targeting the tumor biophysical microenvironment to reduce resistance to immunotherapy
|
Zhang, Tian
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1948 |
Targeting tumor-associated microbiome: A new aspect of modulating tumor microenvironment for cancer therapy
|
Song, Wantong
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1949 |
Targeting vascular inflammation through emerging methods and drug carriers
|
Nong, Jia
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1950 |
Target-responsive DNA/RNA nanomaterials for microRNA sensing and inhibition: The jack-of-all-trades in cancer nanotheranostics?
|
Conde, João
|
|
2015
|
136-137 |
C |
p. 169-183
15 p.
|
artikel
|
| 1951 |
Target specific tight junction modulators
|
Brunner, Joël
|
|
|
136-137 |
C |
p. 266-288
|
artikel
|
| 1952 |
T-cells “à la CAR-T(e)” – Genetically engineering T-cell response against cancer
|
Eisenberg, Vasyl
|
|
2019
|
136-137 |
C |
p. 23-40
|
artikel
|
| 1953 |
Technological advances towards extracellular vesicles mass production
|
Grangier, Alice
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1954 |
Technological and practical challenges of dry powder inhalers and formulations
|
Hoppentocht, M.
|
|
2014
|
136-137 |
C |
p. 18-31
14 p.
|
artikel
|
| 1955 |
Technological and translational challenges for extracellular vesicle in therapy and diagnosis
|
van Niel, Guillaume
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1956 |
Technological development of structural DNA/RNA-based RNAi systems and their applications
|
Jeong, Eun Hye
|
|
2016
|
136-137 |
C |
p. 29-43
15 p.
|
artikel
|
| 1957 |
Technological strategies to estimate and control diffusive passage times through the mucus barrier in mucosal drug delivery
|
Newby, Jay M.
|
|
2018
|
136-137 |
C |
p. 64-81
|
artikel
|
| 1958 |
Technological strategies to overcome the mucus barrier in mucosal drug delivery
|
das Neves, José
|
|
2018
|
136-137 |
C |
p. 1-2
|
artikel
|
| 1959 |
Technologies for intrapericardial delivery of therapeutics and cells
|
Filgueira, Carly S.
|
|
|
136-137 |
C |
p. 222-232
|
artikel
|
| 1960 |
Technology insight: Plant-derived vesicles—How far from the clinical biotherapeutics and therapeutic drug carriers?
|
Cong, Minghui
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1961 |
TEDD title page
|
|
|
2014
|
136-137 |
C |
p. v-
1 p.
|
artikel
|
| 1962 |
Temperature-sensitive polymers to promote heat-triggered drug release from liposomes: Towards bypassing EPR
|
Amin, Mohamadreza
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1963 |
The apparent competitive action of ECM proteases and cross-linking enzymes during fibrosis: Applications to drug discovery
|
Afratis, Nikolaos A.
|
|
|
136-137 |
C |
p. 4-15
|
artikel
|
| 1964 |
The application of 3D cell models to support drug safety assessment: Opportunities & challenges
|
Roth, Adrian
|
|
2014
|
136-137 |
C |
p. 179-189
11 p.
|
artikel
|
| 1965 |
The application of in silico drug-likeness predictions in pharmaceutical research
|
Tian, Sheng
|
|
2015
|
136-137 |
C |
p. 2-10
9 p.
|
artikel
|
| 1966 |
The application of mesenchymal stem cells to treat thermal and radiation burns
|
Rodgers, Kathleen
|
|
2018
|
136-137 |
C |
p. 75-81
|
artikel
|
| 1967 |
The applications of 3D printing in wound healing: The external delivery of stem cells and antibiosis
|
Yu, Qingtong
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1968 |
The battle of “nano” paclitaxel
|
Sofias, Alexandros Marios
|
|
2017
|
136-137 |
C |
p. 20-30
|
artikel
|
| 1969 |
The biology of mucus: Composition, synthesis and organization
|
Bansil, Rama
|
|
2018
|
136-137 |
C |
p. 3-15
|
artikel
|
| 1970 |
The blood-brain barrier: Physiology and strategies for drug delivery
|
Pandit, Rucha
|
|
|
136-137 |
C |
p. 1-14
|
artikel
|
| 1971 |
The challenges facing block copolymer micelles for cancer therapy: In vivo barriers and clinical translation
|
Eetezadi, Sina
|
|
2015
|
136-137 |
C |
p. 7-22
16 p.
|
artikel
|
| 1972 |
The challenges of multiple organ dysfunction syndrome and extra-corporeal circuits for drug delivery in critically ill patients
|
Hites, Maya
|
|
2014
|
136-137 |
C |
p. 12-21
10 p.
|
artikel
|
| 1973 |
The chorioallantoic membrane as a bio-barrier model for the evaluation of nanoscale drug delivery systems for tumour therapy
|
Preis, Eduard
|
|
|
136-137 |
C |
p. 317-336
|
artikel
|
| 1974 |
The clinical role of host and bacterial-derived extracellular vesicles in pneumonia
|
Jung, Anna Lena
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1975 |
The design of peptide-amphiphiles as functional ligands for liposomal anticancer drug and gene delivery
|
Kuang, Huihui
|
|
2017
|
136-137 |
C |
p. 80-101
22 p.
|
artikel
|
| 1976 |
The dynamic, motile and deformative properties of RNA nanoparticles facilitate the third milestone of drug development
|
Li, Xin
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1977 |
The effect of low- and high-penetration light on localized cancer therapy
|
Costa, Daniel F.
|
|
2019
|
136-137 |
C |
p. 105-116
|
artikel
|
| 1978 |
The effect of pathophysiology on pharmacokinetics in the critically ill patient — Concepts appraised by the example of antimicrobial agents
|
Blot, Stijn I.
|
|
2014
|
136-137 |
C |
p. 3-11
9 p.
|
artikel
|
| 1979 |
The effects of dietary and herbal phytochemicals on drug transporters
|
Li, Yan
|
|
2017
|
136-137 |
C |
p. 45-62
18 p.
|
artikel
|
| 1980 |
The effects of major burn related pathophysiological changes on the pharmacokinetics and pharmacodynamics of drug use: An appraisal utilizing antibiotics
|
Udy, Andrew A.
|
|
2018
|
136-137 |
C |
p. 65-74
|
artikel
|
| 1981 |
The effects of protein corona on in vivo fate of nanocarriers
|
Xiao, Qingqing
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1982 |
The electrophysiological development of cardiomyocytes
|
Liu, Jie
|
|
2016
|
136-137 |
C |
p. 253-273
21 p.
|
artikel
|
| 1983 |
The emerging role of physiologically based pharmacokinetic modelling in solid drug nanoparticle translation
|
Siccardi, Marco
|
|
2018
|
136-137 |
C |
p. 116-121
|
artikel
|
| 1984 |
The enigma of stem cell-based therapies – how to conquer the death valley of therapy development
|
Steinhoff, Gustav
|
|
2017
|
136-137 |
C |
p. 1
|
artikel
|
| 1985 |
The era of nano-bionic: 2D materials for wearable and implantable body sensors
|
Silvestri, Alessandro
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1986 |
The ethics of stem cells revisited
|
de Miguel-Beriain, Iñigo
|
|
2015
|
136-137 |
C |
p. 176-180
5 p.
|
artikel
|
| 1987 |
The extracellular matrix in breast cancer
|
Insua-Rodríguez, Jacob
|
|
2016
|
136-137 |
C |
p. 41-55
15 p.
|
artikel
|
| 1988 |
The extracellular matrix of hematopoietic stem cell niches
|
Lee-Thedieck, Cornelia
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1989 |
The formulation of nanomedicines for treating tuberculosis
|
Costa, Ana
|
|
2016
|
136-137 |
C |
p. 102-115
14 p.
|
artikel
|
| 1990 |
The global tuberculosis situation and the inexorable rise of drug-resistant disease
|
Marais, Ben J.
|
|
2016
|
136-137 |
C |
p. 3-9
7 p.
|
artikel
|
| 1991 |
The good and the bad collagens of fibrosis – Their role in signaling and organ function
|
Karsdal, M.A.
|
|
2017
|
136-137 |
C |
p. 43-56
|
artikel
|
| 1992 |
The hepatic lipidome: From basic science to clinical translation
|
ten Hove, Marit
|
|
|
136-137 |
C |
p. 180-197
|
artikel
|
| 1993 |
The immunostimulatory nature of mRNA lipid nanoparticles
|
Sharma, Preeti
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1994 |
The importance of nanoparticle physicochemical characterization for immunology research: What we learned and what we still need to understand
|
Clogston, Jeffrey D.
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1995 |
The importance of pre-formulation studies and of 3D-printed nasal casts in the success of a pharmaceutical product intended for nose-to-brain delivery
|
Deruyver, Laura
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1996 |
The integration of hyperthermia and drug delivery
|
Dunne, Michael
|
|
|
136-137 |
C |
p. 1-2
|
artikel
|
| 1997 |
The interaction between particles and vascular endothelium in blood flow
|
Li, Xiaotong
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1998 |
The interplay between PEGylated nanoparticles and blood immune system
|
Guo, Chen
|
|
|
136-137 |
C |
p.
|
artikel
|
| 1999 |
The intersection of circadian rhythms and the blood-brain barrier with drug efficacy and delivery in neurological disorders
|
Schindler, Kyra A.
|
|
|
136-137 |
C |
p.
|
artikel
|
| 2000 |
The in vivo drug delivery pattern of the organelle-targeting small molecules
|
Fang, Zhao
|
|
|
136-137 |
C |
p.
|
artikel
|
Tijdschrift beschrijving